<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Early versus delayed antiretroviral treatment in HIV‐positive people with cryptococcal meningitis - Eshun‐Wilson, I - 2018 | Cochrane Library</title> <meta content="Early versus delayed antiretroviral treatment in HIV‐positive people with cryptococcal meningitis - Eshun‐Wilson, I - 2018 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD009012.pub3/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Early versus delayed antiretroviral treatment in HIV‐positive people with cryptococcal meningitis - Eshun‐Wilson, I - 2018 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD009012.pub3/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD009012.pub3" name="dc.identifier" scheme="DOI"/> <meta content="Early versus delayed antiretroviral treatment in HIV‐positive people with cryptococcal meningitis" name="citation_title"/> <meta content="Ingrid Eshun‐Wilson" name="citation_author"/> <meta content="Stellenbosch University" name="citation_author_institution"/> <meta content="wilson.ingrid@gmail.com" name="citation_author_email"/> <meta content="Mbah P Okwen" name="citation_author"/> <meta content="Yaoundé Central Hospital" name="citation_author_institution"/> <meta content="Marty Richardson" name="citation_author"/> <meta content="Liverpool School of Tropical Medicine" name="citation_author_institution"/> <meta content="Tihana Bicanic" name="citation_author"/> <meta content="St George's University of London" name="citation_author_institution"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="7" name="citation_issue"/> <meta content="10.1002/14651858.CD009012.pub3" name="citation_doi"/> <meta content="2018" name="citation_date"/> <meta content="2018/07/24" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD009012.pub3/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD009012.pub3/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD009012.pub3/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="AIDS-Related Opportunistic Infections [drug therapy]; Amphotericin B [administration &amp; dosage, adverse effects]; Anti-HIV Agents [*administration &amp; dosage]; Antifungal Agents [*administration &amp; dosage, adverse effects]; Cause of Death; Drug Administration Schedule; Fluconazole [administration &amp; dosage, adverse effects]; HIV Infections [complications, *drug therapy, mortality]; Meningitis, Cryptococcal [complications, *drug therapy]; Randomized Controlled Trials as Topic" name="citation_keywords"/> <meta content="" name="citation_fulltext_world_readable"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009012.pub3&amp;doi=10.1002/14651858.CD009012.pub3&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009012.pub3&amp;doi=10.1002/14651858.CD009012.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009012.pub3&amp;doi=10.1002/14651858.CD009012.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009012.pub3&amp;doi=10.1002/14651858.CD009012.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009012.pub3&amp;doi=10.1002/14651858.CD009012.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009012.pub3&amp;doi=10.1002/14651858.CD009012.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009012.pub3&amp;doi=10.1002/14651858.CD009012.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009012.pub3&amp;doi=10.1002/14651858.CD009012.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009012.pub3&amp;doi=10.1002/14651858.CD009012.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009012.pub3&amp;doi=10.1002/14651858.CD009012.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009012.pub3&amp;doi=10.1002/14651858.CD009012.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009012.pub3&amp;doi=10.1002/14651858.CD009012.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009012.pub3&amp;doi=10.1002/14651858.CD009012.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009012.pub3&amp;doi=10.1002/14651858.CD009012.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009012.pub3&amp;doi=10.1002/14651858.CD009012.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009012.pub3&amp;doi=10.1002/14651858.CD009012.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009012.pub3&amp;doi=10.1002/14651858.CD009012.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009012.pub3&amp;doi=10.1002/14651858.CD009012.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009012.pub3&amp;doi=10.1002/14651858.CD009012.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009012.pub3&amp;doi=10.1002/14651858.CD009012.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009012.pub3&amp;doi=10.1002/14651858.CD009012.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009012.pub3&amp;doi=10.1002/14651858.CD009012.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009012.pub3&amp;doi=10.1002/14651858.CD009012.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739774054000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739774000000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739774081000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1559916434000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1559916434000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1559916434000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1559916434000"}};Liferay.authToken="QzbxnhyM";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD009012\x2epub3\x26doi\x3d10\x2e1002\x2f14651858\x2eCD009012\x2epub3\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009012\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD009012\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1559916434000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","ms","fa","zh_HANS"],languageCode:"en",accessStatus:"open-access",doi:"10.1002/14651858.CD009012.pub3",title:"Early versus delayed antiretroviral treatment in HIV\\u2010positive people with cryptococcal meningitis",firstPublishedDate:"Jul 24, 2018 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Infectious Diseases Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738735355000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=QzbxnhyM&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD009012.pub3&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD009012.pub3';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD009012.pub3/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD009012.pub3/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD009012.pub3%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD009012.pub3/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD009012.pub3/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD009012.pub3/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD009012.pub3/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD009012.PUB3" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;摘要&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;简语概要&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD009012.pub3/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD009012.PUB3" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD009012.pub3/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD009012.pub3/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>4056 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD009012.pub3" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009012.pub3/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009012.pub3/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009012.pub3/full#CD009012-abs-0003"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009012.pub3/full#CD009012-sec-0112"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009012.pub3/full#CD009012-sec-0023"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009012.pub3/full#CD009012-sec-0024"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009012.pub3/full#CD009012-sec-0029"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009012.pub3/full#CD009012-sec-0030"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009012.pub3/full#CD009012-sec-0058"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009012.pub3/full#CD009012-sec-0104"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD009012.pub3/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009012.pub3/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009012.pub3/appendices#CD009012-sec-0117"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009012.pub3/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009012.pub3/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD009012.pub3/media/CDSR/CD009012/table_n/CD009012StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD009012.pub3/media/CDSR/CD009012/table_n/CD009012StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009012.pub3/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009012.pub3/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009012.pub3/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD009012.pub3/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD009012.pub3/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD009012.pub3/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2018 The Authors. Cochrane Database of Systematic Reviews published by John Wiley &amp; Sons, Ltd. on behalf of The Cochrane Collaboration." data-creative-commons="true" href="/cdsr/doi/10.1002/14651858.CD009012.pub3/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> <div class="inline-status-wrapper"> </div> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Early versus delayed antiretroviral treatment in HIV‐positive people with cryptococcal meningitis </h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD009012.pub3/information#CD009012-cr-0002"><i class="icon corresponding-author fa fa-envelope"></i>Ingrid Eshun‐Wilson</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD009012.pub3/information#CD009012-cr-0003">Mbah P Okwen</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD009012.pub3/information#CD009012-cr-0004">Marty Richardson</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD009012.pub3/information#CD009012-cr-0005">Tihana Bicanic</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD009012.pub3/information/en#CD009012-sec-0122">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 24 July 2018 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD009012.pub3/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD009012.pub3">https://doi.org/10.1002/14651858.CD009012.pub3</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD009012-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD009012-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD009012-abs-0002">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD009012-abs-0006">فارسی</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD009012-abs-0008">简体中文</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD009012-abs-0001" lang="en"> <section id="CD009012-sec-0001"> <h3 class="title" id="CD009012-sec-0001">Background</h3> <p>There remains uncertainty about the optimum timing of antiretroviral therapy (ART) initiation in HIV‐positive people with cryptococcal meningitis. This uncertainty is the result of conflicting data on the mortality risk and occurrence of immune reconstitution inflammatory syndrome (IRIS) when ART is initiated less than four weeks after cryptococcal meningitis treatment is commenced. </p> </section> <section id="CD009012-sec-0002"> <h3 class="title" id="CD009012-sec-0002">Objectives</h3> <p>To compare the outcomes of early initiation of ART (less than four weeks after starting antifungal treatment) versus delayed initiation of ART (four weeks or more after starting antifungal treatment) in HIV‐positive people with concurrent cryptococcal meningitis. </p> </section> <section id="CD009012-sec-0003"> <h3 class="title" id="CD009012-sec-0003">Search methods</h3> <p>We searched the Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE, and Embase for trials published between 1 January 1980 and 7 August 2017. We additionally searched international trial registries, including ClinicalTrials.gov and WHO International Clinical Trials Registry Platform (ICTRP), and conference abstracts from the International AIDS Society (IAS) and the Conference on Retroviruses and Opportunistic Infections (CROI) for ongoing or unpublished studies between 2015 and 2017. We reviewed reference lists of included studies to identify additional studies. </p> </section> <section id="CD009012-sec-0004"> <h3 class="title" id="CD009012-sec-0004">Selection criteria</h3> <p>We included randomized controlled trials (RCTs) that compared early versus delayed ART initiation in HIV‐positive people with cryptococcal meningitis. Children, adults, and adolescents from any setting were eligible for inclusion. </p> </section> <section id="CD009012-sec-0005"> <h3 class="title" id="CD009012-sec-0005">Data collection and analysis</h3> <p>Two review authors independently applied the inclusion criteria and extracted data. We presented dichotomous outcomes as risk ratios (RR) with 95% confidence intervals (CIs). We presented time‐to‐death data as hazard ratios with 95% CIs. We assessed the certainty of the evidence using the GRADE approach. </p> </section> <section id="CD009012-sec-0006"> <h3 class="title" id="CD009012-sec-0006">Main results</h3> <p>Four trials including 294 adult participants met the inclusion criteria of this review. Participants were predominantly from low‐ and middle‐income countries. Two trials treated cryptococcal meningitis with amphotericin B and fluconazole; a third trial used fluconazole monotherapy; and the fourth trial did not specify the antifungal used. </p> <p>Early ART initiation may increase all‐cause mortality compared to delayed ART initiation (RR 1.42, 95% CI 1.02 to 1.97; 294 participants, 4 trials; low‐certainty evidence). Early ART initiation may reduce relapse of cryptococcal meningitis compared to delayed ART initiation (RR 0.27, 95% CI 0.07 to 1.04; 205 participants, 2 trials, low‐certainty evidence). We are uncertain whether early ART initiation increases or reduces cryptococcal IRIS events compared to delayed ART initiation (RR 3.56, 95% CI 0.51 to 25.02; 205 participants, 2 trials; I<sup>2</sup> = 54%; very low‐certainty evidence). We are uncertain if early ART initiation increases or reduces virological suppression at six months compared to delayed ART initiation (RR 0.93, 95% CI 0.72 to 1.22; 205 participants, 2 trials; I<sup>2</sup> statistic = 0%; very low‐certainty evidence). </p> <p>We were unable to pool results related to rate of fungal clearance for the two trials that reported this outcome; individual trial results indicated that there was no difference in cerebrospinal fluid fungal clearance between trial arms. Similarly, we were unable to pool results on adverse events for the trials reporting on this outcome; individual trial results indicated no difference in the occurrence of grade 3 to 5 adverse events between trial arms. </p> <p>Three of the four included trials had an overall low or unclear risk of bias related to the primary outcome of all‐cause mortality. However, we assessed one trial as at high risk of bias due to selective outcome reporting and other bias. This, in addition to the few clinical events and imprecision of effect estimates, led to downgrading of the evidence to low or very low certainty. </p> </section> <section id="CD009012-sec-0007"> <h3 class="title" id="CD009012-sec-0007">Authors' conclusions</h3> <p>The results of this review are relevant to HIV‐positive adults with cryptococcal meningitis in low‐ and middle‐income countries. These data suggest a higher risk of mortality among people who initiate ART within four weeks of cryptococcal meningitis diagnosis. However, it is unclear if this higher mortality risk is related to cryptococcal meningitis‐IRIS. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD009012-abs-0003" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD009012-abs-0003">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD009012-abs-0004">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD009012-abs-0007">فارسی</a> </li> <li class="section-language"> <a class="" href="full/ms#CD009012-abs-0005">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD009012-abs-0009">简体中文</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD009012-abs-0003" lang="en"> <h3>Timing of antiretroviral therapy initiation in HIV‐positive people with cryptococcal meningitis </h3> <p><b>What is the aim of this review?</b> </p> <p>The aim of this Cochrane Review was to determine whether initiating antiretroviral therapy (ART) within four weeks of cryptococcal meningitis diagnosis resulted in a higher risk of dying or developing other complications than waiting more than four weeks to initiate ART. </p> <p><b>Key messages</b> </p> <p>Initiating ART within four weeks of cryptococcal meningitis diagnosis may result in more deaths than initiating ART after four weeks. However, initiating ART early may result in a reduction in relapses of cryptococcal meningitis after adequate treatment. There was insufficient evidence to answer questions related to other complications. </p> <p><b>What was studied in the review?</b> </p> <p>Cryptococcal meningitis is a fungal infection of the brain and the membranes covering the brain that occurs most frequently in people with weakened immune systems, such as people who are HIV‐positive. Some studies have shown that HIV‐positive people who start ART soon after initiating cryptococcal meningitis treatment (within four weeks) may deteriorate and die more frequently than those who delay treatment for a longer period (more than four weeks). This higher risk of death in the early ART group has been attributed to the occurrence of a condition called immune reconstitution inflammatory syndrome (IRIS). When ART is initiated, HIV‐positive people with underlying infections such as cryptococcal meningitis may paradoxically develop a deterioration in their condition as their body's immune system attacks the fungus, resulting in worsening symptoms and sometimes death. It has been proposed that IRIS is the cause of more deaths in early ART initiators than in delayed ART initiators. Despite adequate treatment of cryptococcal meningitis with antifungal drugs, a relapse of the disease may occur in some HIV‐positive people with cryptococcal meningitis. To date there have been few trials investigating the effect of ART on mortality, frequency of IRIS, or relapse. </p> <p><b>What are the main results of the review?</b> </p> <p>We found four relevant trials that compared HIV‐positive adults who had cryptococcal meningitis and who initiated ART within four weeks of cryptococcal meningitis diagnosis with those who initiated ART after four weeks. </p> <p>Pooling the results of these four trials suggested that early ART initiation may increase the frequency of death in HIV‐positive people with cryptococcal meningitis (low‐certainty evidence). Early ART initiators may be less likely to have relapses of cryptococcal meningitis (low‐certainty evidence). We were unable to draw conclusions regarding IRIS frequency as the certainty of the evidence contributing to the IRIS assessment was very low. We are uncertain as to whether or not early ART initiation increases or reduces virological suppression at six months compared to delayed ART initiation (very low‐certainty evidence). </p> <p>Overall, few trials met the inclusion criteria for this review, which made it hard to draw definite conclusions on the association between ART timing and cryptococcal meningitis in HIV‐positive people. </p> <p><b>How up to date is the review?</b> </p> <p>We searched for studies up to 7 August 2017.</p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD009012-sec-0112" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD009012-sec-0112"></div> <h3 class="title" id="CD009012-sec-0113">Implications for practice</h3> <section id="CD009012-sec-0113"> <p>Despite the low certainty of the evidence, it appears that initiating antiretroviral therapy (ART) within four weeks of cryptococcal meningitis diagnosis increases the risk of mortality compared to delaying ART beyond four weeks. Clinicians and guideline developers need to seriously consider the severe nature of the potential harms of initiating ART early in HIV‐positive people with cryptococcal meningitis. Findings from this Cochrane Review contributed to the formulation of the current World Health Organization (WHO) guidelines for the diagnosis, prevention, and management of cryptococcal disease in HIV‐positive adults, adolescents, and children (<a href="./references#CD009012-bbs2-0042" title="World Health Organization. Guidelines for the diagnosis, prevention and management of cryptococcal disease in HIV‐infected adults, adolescents and children. Supplement to the 2016 consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection. www.who.int/hiv/pub/guidelines/cryptococcal‐disease/en/ (accessed prior to 25 April 2018). ">WHO 2018</a>). </p> </section> <h3 class="title" id="CD009012-sec-0114">Implications for research</h3> <section id="CD009012-sec-0114"> <p>With this suggestion of a higher risk of mortality in HIV‐positive people with cryptococcal meningitis who initiate ART early, it is unlikely that more randomized controlled trials will be conducted that evaluate early versus delayed ART as an intervention in people with cryptococcal meningitis. Questions regarding how to best manage patients who develop cryptococcal meningitis soon after ART initiation were not addressed in this Cochrane Review and will become more relevant as rapid ART initiation becomes widespread. </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD009012-sec-0023" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD009012-sec-0023"></div> <div class="table" id="CD009012-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Early ART compared to delayed ART initiation in HIV‐positive people with cryptococcal meningitis</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Early ART compared to delayed ART initiation in HIV‐positive people with cryptococcal meningitis</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> HIV‐positive people with cryptococcal meningitis<br/> <b>Setting:</b> global<br/> <b>Intervention:</b> early ART initiation (less than 4 weeks after initiation of cryptococcal meningitis treatment)<br/> <b>Comparison:</b> delayed ART initiation (more than 4 weeks after initiation of cryptococcal meningitis treatment) </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="center" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Number of participants<br/> (trials)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with delayed ART</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with early ART</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>All‐cause mortality at 6 to 12 months</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>311 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>442 per 1000<br/> (317 to 613) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 1.42<br/> (1.02 to 1.97) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>294<br/> (4 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> LOW<sup>1,2,3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Early ART initiation may increase the risk of mortality at 6 to 12 months.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cryptococcal meningitis relapse</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>87 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>24 per 1000<br/> (6 to 91) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 0.27<br/> (0.07 to 1.04) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>205<br/> (2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> LOW<sup>4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Early ART initiation may reduce relapses of cryptococcal meningitis compared to delayed ART initiation. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cryptococcal IRIS</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>87 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>311 per 1000<br/> (45 to 1000) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 3.56<br/> (0.51 to 25.02) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>205<br/> (2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW<sup>4,5,6</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>We are uncertain as to whether or not early ART initiation increases or reduces cryptococcal IRIS events compared to delayed ART initiation. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>HIV virological suppression at 6 months (viral load &lt; 400 copies/mL)</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>534 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>497 per 1000<br/> (384 to 651) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 0.93 (0.72 to 1.22)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>205<br/> (2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW<sup>7,8</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>We are uncertain as to whether or not early ART initiation increases or reduces virological suppression at 6 months compared to delayed ART initiation. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% CI) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). </p> <p><b>Abbreviations: ART:</b> antiretroviral therapy; <b>CI:</b> confidence interval; <b>IRIS:</b> immune reconstitution inflammatory syndrome; <b>RCT:</b> randomized controlled trial; <b>RR:</b> risk ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/> <b>Moderate certainty:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/> <b>Low certainty:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/> <b>Very low certainty:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>Risk of bias: downgraded by a half point due to high risk of other bias in <a href="./references#CD009012-bbs2-0003" title="MakadzangeAT , NdhlovuCE , TakarindaK , ReidM , KurangwaM , GonaP , et al. Early versus delayed initiation of antiretroviral therapy for concurrent HIV infection and cryptococcal meningitis in sub‐Saharan Africa. Clinical Infectious Diseases2010;50(11):1532‐8. [DOI: 10.1086/652652; CN‐00748368] ">Makadzange 2010</a>.<br/> <sup>2</sup>Imprecision: downgraded by 1 for wide CIs including no effect and appreciable harm. In addition, there were few clinical events (&lt; 200).<br/> <sup>3</sup>Heterogeneity: downgraded by a half point due to qualitative heterogeneity (different drug regimens and study methods).<br/> <sup>4</sup>Imprecision: downgraded by 2 for wide CIs and very few clinical events.<br/> <sup>5</sup>Risk of bias: downgraded by 1 as IRIS outcome assessors in <a href="./references#CD009012-bbs2-0001" title="BissonGP , MolefiM , BellamyS , ThakurR , SteenhoffA , TamuhlaN , et al. Early versus delayed antiretroviral therapy and cerebrospinal fluid fungal clearance in adults with HIV and cryptococcal meningitis. Clinical Infectious Diseases2013;56(8):1165‐73. [DOI: 10.1093/cid/cit019; CN‐00861211] ">Bisson 2013</a> were unblinded.<br/> <sup>6</sup>Indirectness: downgraded 1 as despite case definition, diagnosing IRIS can be very subjective/misdiagnosed.<br/> <sup>7</sup>Risk of bias: downgraded by 2 as not all those who were randomized to early or delayed ART received ART. In addition, not all those who received ART had a viral load done. It cannot be assumed that these results are missing at random. This is explored in the sensitivity analyses.<br/> <sup>8</sup>Imprecision: downgraded by 1 for few clinical events (&lt; 200). </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD009012-sec-0024" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD009012-sec-0024"></div> <p>HIV/AIDS remains one of the world's most significant public health challenges, particularly in low‐ and middle‐income countries. Antiretroviral therapy (ART) has substantially improved HIV prognosis by reducing associated morbidity and mortality. However uncertainty remains as to the optimal time for ART initiation when an HIV‐positive person is co‐infected with an opportunistic infection, particularly cryptococcal meningitis. </p> <section id="CD009012-sec-0025"> <h3 class="title" id="CD009012-sec-0025">Description of the condition</h3> <p>Cryptococcal meningitis is an important opportunistic AIDS‐defining infection and a major contributor to high mortality before and after ART is initiated (<a href="./references#CD009012-bbs2-0012" title="BicanicT , HarrisonTS . Cryptococcal meningitis. British Medical Bulletin2005;72:99‐118. ">Bicanic 2005</a>; <a href="./references#CD009012-bbs2-0040" title="World Health Organization. HIV/AIDS: prevention screening and management of common coinfections. Consolidated ARV guidelines, June 2013. www.who.int/hiv/pub/guidelines/arv2013/coinfection/prevcoinfection/en/index5.html (accessed prior to 31 June 2017). ">WHO 2013</a>). It is caused by the encapsulated yeast <i>Cryptococcus neoformans</i>, which is inhaled as small yeast cells. Patients may present with headache, fever, malaise, and altered mental status; they may also have signs of meningism, papilloedema, and focal neurological deficits. Raised intracranial pressure likely results from poor absorption of cerebrospinal fluid (CSF); this is usually responsible for the central nervous system manifestations. In addition to clinical history and physical examination, laboratory investigations assist accurate and timely diagnosis; recommended laboratory investigations include cryptococcal antigen (CrAg) in CSF or serum, India Ink microscopy of CSF, or culture (<a href="./references#CD009012-bbs2-0012" title="BicanicT , HarrisonTS . Cryptococcal meningitis. British Medical Bulletin2005;72:99‐118. ">Bicanic 2005</a>; <a href="./references#CD009012-bbs2-0040" title="World Health Organization. HIV/AIDS: prevention screening and management of common coinfections. Consolidated ARV guidelines, June 2013. www.who.int/hiv/pub/guidelines/arv2013/coinfection/prevcoinfection/en/index5.html (accessed prior to 31 June 2017). ">WHO 2013</a>). </p> <p>The case fatality rate in people with cryptococcal meningitis, the most common presentation of HIV‐related cryptococcal disease in adults, remains unacceptably high, particularly in sub‐Saharan Africa, where it is between 35% to 65% compared with 10% to 20% in most high‐income countries (<a href="./references#CD009012-bbs2-0012" title="BicanicT , HarrisonTS . Cryptococcal meningitis. British Medical Bulletin2005;72:99‐118. ">Bicanic 2005</a>; <a href="./references#CD009012-bbs2-0034" title="ParkBJ , WannemuehlerKA , MarstonBJ , GovenderN , PappasPG , ChillerTM . Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS. AIDS2009;23(4):525‐30. ">Park 2009</a>; <a href="./references#CD009012-bbs2-0041" title="World Health Organization. Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection. Recommendations for a public health approach. Second edition. www.who.int/hiv/pub/arv/arv‐2016/en/ (accessed prior to 13 September 2017). ">WHO 2016</a>). In people who are immunocompromised, untreated cryptococcal meningitis will uniformly lead to death in a few weeks (<a href="./references#CD009012-bbs2-0030" title="MwabaP , MwansaJ , ChintuC , PobeeJ , ScarboroughM , PortsmouthS , et al. Clinical presentation, natural history, and cumulative death rates of 230 adults with primary cryptococcal meningitis in Zambian AIDS patients treated under local conditions. Postgraduate Medical Journal2001;77(914):769–73. ">Mwaba 2001</a>). Cryptococcal meningitis is a leading cause of death in HIV‐positive people and typically affects those with low cluster of differentiation 4 (CD4) counts (<a href="./references#CD009012-bbs2-0035" title="RajasinghamR , SmithRM , ParkBJ , JarvisJN , GovenderNP , ChillerTM , et al. Global burden of disease of HIV‐associated cryptococcal meningitis: an updated analysis. Lancet Infectious Diseases2017;17(8):873‐81. ">Rajasingham 2017</a>; <a href="./references#CD009012-bbs2-0043" title="WilliamsonPR , JarvisJN , PanackalAA , FisherMC , MolloySF , LoyseA , et al. Cryptococcal meningitis: epidemiology, immunology, diagnosis and therapy. Nature Reviews Neurology2017;13(1):13‐24. ">Williamson 2017</a>). Amphotericin B, flucytosine, and the azoles are the mainstay antifungal treatments for cryptococcal meningitis. Drug toxicity related to amphotericin B has been reported in up to 60% of patients (<a href="./references#CD009012-bbs2-0016" title="BicanicT , BottomleyC , LoyseA , BrouwerAE , MuzooraC , TaseeraK , et al. Toxicity of amphotericin B deoxycholate‐based induction therapy in patients with HIV‐associated cryptococcal meningitis. Antimicrobial Agents and Chemotherapy2015;59(12):7224‐31. [DOI: 10.1128/AAC.01698‐15] ">Bicanic 2015</a>; <a href="./references#CD009012-bbs2-0029" title="MeiringS , Fortuin‐de SmidtM , KularatneR , DawoodH , GovenderNP , GERMS‐SA . Prevalence and hospital management of amphotericin B deoxycholate‐related toxicities during treatment of HIV‐associated cryptococcal meningitis in South Africa. PLoS Neglected Tropical Diseases2016;10(7):e0004865. [DOI: 10.1371/journal.pntd.0004865] ">Meiring 2016</a>). Cryptococcal meningitis is less frequently described in children, although cases do occur (<a href="./references#CD009012-bbs2-0033" title="AIDSinfo . Guidelines for the prevention and treatment of opportunistic infections among HIV‐exposed and HIV‐infected children. https://aidsinfo.nih.gov/guidelines/html/4/adult‐and‐adolescent‐opportunistic‐infection/0 (accessed prior to 29 September 2017). ">NIH 2017b</a>; <a href="./references#CD009012-bbs2-0038" title="TinasheKN , MasanganiseF , HagenF , Bwakura‐DangarembiziMF , TicklayIMH , RoberstonVJ . Cryptococcal meningitis presenting as a complication in HIV‐infected children: a case series from sub‐Saharan Africa. Pediatric Infectious Disease Journal2016;35(9):979‐80. ">Tinashe 2016</a>). The best time to initiate ART in those recently diagnosed with cryptococcal meningitis remains an area of debate. </p> </section> <section id="CD009012-sec-0026"> <h3 class="title" id="CD009012-sec-0026">Description of the intervention</h3> <p>The treatment of cryptococcal meningitis is usually initiated with a combination of antifungal agents (induction phase) followed by a single oral antifungal (consolidation phase) (<a href="./references#CD009012-bbs2-0032" title="AIDSinfo . Guidelines for the prevention and treatment of opportunistic infections in HIV‐infected adults and adolescents: recommendations from the Centers for Disease Control and Prevention, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. aidsinfo.nih.gov/contentfiles/lvguidelines/adult_oi.pdf (accessed prior to 13 September 2017). ">NIH 2017a</a>; <a href="./references#CD009012-bbs2-0033" title="AIDSinfo . Guidelines for the prevention and treatment of opportunistic infections among HIV‐exposed and HIV‐infected children. https://aidsinfo.nih.gov/guidelines/html/4/adult‐and‐adolescent‐opportunistic‐infection/0 (accessed prior to 29 September 2017). ">NIH 2017b</a>; <a href="./references#CD009012-bbs2-0042" title="World Health Organization. Guidelines for the diagnosis, prevention and management of cryptococcal disease in HIV‐infected adults, adolescents and children. Supplement to the 2016 consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection. www.who.int/hiv/pub/guidelines/cryptococcal‐disease/en/ (accessed prior to 25 April 2018). ">WHO 2018</a>). The preferred induction regimen is amphotericin B combined with flucytosine, followed by oral fluconazole for the consolidation phase, and until immune reconstitution on ART. Current guidelines recommend initiating ART within four to six weeks after cryptococcal meningitis treatment has commenced (<a href="./references#CD009012-bbs2-0042" title="World Health Organization. Guidelines for the diagnosis, prevention and management of cryptococcal disease in HIV‐infected adults, adolescents and children. Supplement to the 2016 consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection. www.who.int/hiv/pub/guidelines/cryptococcal‐disease/en/ (accessed prior to 25 April 2018). ">WHO 2018</a>). </p> </section> <section id="CD009012-sec-0027"> <h3 class="title" id="CD009012-sec-0027">How the intervention might work</h3> <p>There remains uncertainty as to when ART should be initiated in people with cryptococcal meningitis. This is related to reports of higher mortality rates among patients who initiate ART early in cryptococcal meningitis treatment (<a href="./references#CD009012-bbs2-0045" title="NjeiB , KongnyuyEJ , KumarS , OkwenMP , SankarMJ , MbuagbawL . Optimal timing for antiretroviral therapy initiation in patients with HIV infection and concurrent cryptococcal meningitis. Cochrane Database of Systematic Reviews2013, Issue 2. [DOI: 10.1002/14651858.CD009012.pub2] ">Njei 2013</a>). Immune reconstitution inflammatory syndrome (IRIS), an exaggerated inflammatory response that can cause a paradoxical clinical deterioration soon after ART initiation, has frequently been described in association with cryptococcal meningitis. Some reports suggest that IRIS may contribute to higher mortality among HIV‐positive people who initiate ART early after a cryptococcal meningitis diagnosis as compared to starting later, however there is no clear evidence of such an association (<a href="./references#CD009012-bbs2-0014" title="BicanicT , MeintjesG , RebeK , WilliamsA , LoyseA , WoodR , et al. Immune reconstitution inflammatory syndrome in HIV‐associated cryptococcal meningitis: a prospective study. Journal of Acquired Immune Deficiency Syndromes2009;51(2):130‐4. ">Bicanic 2009</a>; <a href="./references#CD009012-bbs2-0031" title="MüllerM , WandelS , ColebundersR , AttiaS , FurrerH , EggerM , IeDEASouthern , CentralAfrica . Immune reconstitution inflammatory syndrome in patients starting antiretroviral therapy for HIV infection: a systematic review and meta‐analysis. Lancet Infectious Diseases2010;10(4):251‐61. ">Müller 2010</a>; <a href="./references#CD009012-bbs2-0037" title="ShelburneSA3rd , DarcourtJ , WhiteACJr , GreenbergSB , HamillRJ , AtmarRL , et al. The role of immune reconstitution inflammatory syndrome in AIDS‐related Cryptococcus neoformans disease in the era of highly active antiretroviral therapy. Clinical Infectious Diseases2005;40(7):1049‐52. ">Shelburne 2005</a>). Additionally, in many settings where cryptococcal meningitis is prevalent, amphotericin B and flucytosine are unavailable due to resource constraints. In such settings the use of suboptimal cryptococcal meningitis treatment regimens with inadequate fungal clearance may put patients at increased risk of developing relapses and IRIS (<a href="./references#CD009012-bbs2-0013" title="BicanicT , HarrisonT , NiepiekloA , DyakopuN , MeintjesG . Symptomatic relapse of HIV‐associated cryptococcal meningitis after initial fluconazole monotherapy: the role of fluconazole resistance and immune reconstitution. Clinical Infectious Diseases2006;43(8):1069‐73. ">Bicanic 2006</a>; <a href="./references#CD009012-bbs2-0027" title="LoyseA , ThangarajH , EasterbrookP , FordN , RoyM , ChillerT , et al. Cryptococcal meningitis: improving access to essential antifungal medicines in resource‐poor countries. Lancet Infectious Diseases2013;13(7):629‐37. [DOI: 10.1016/S1473‐3099(13)70078‐1] ">Loyse 2013</a>). </p> <p>Immune reconstitution inflammatory syndrome related to cryptococcal disease has been defined as events occurring within 12 months of ART initiation, reintroduction, or regimen switching after previous failure manifesting clinically as worsening disease with one or more inflammatory manifestations of cryptococcosis (meningitis, lymphadenopathy, intracranial space‐occupying lesion or lesions, multifocal disease, cutaneous or soft‐tissue lesions, pneumonitis, or pulmonary nodules) (<a href="./references#CD009012-bbs2-0023" title="HaddowLJ , ColebundersR , MeintjesG , LawnSD , ElliottJH , ManabeYC , et al. Cryptococcal immune reconstitution inflammatory syndrome in HIV‐1‐infected individuals: proposed clinical case definitions. Lancet Infectious Diseases2010;10(11):791‐802. ">Haddow 2010</a>). </p> <p>Although many recommendations support delaying ART initiation in people with cryptococcal meningitis (<a href="./references#CD009012-bbs2-0032" title="AIDSinfo . Guidelines for the prevention and treatment of opportunistic infections in HIV‐infected adults and adolescents: recommendations from the Centers for Disease Control and Prevention, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. aidsinfo.nih.gov/contentfiles/lvguidelines/adult_oi.pdf (accessed prior to 13 September 2017). ">NIH 2017a</a>; <a href="./references#CD009012-bbs2-0042" title="World Health Organization. Guidelines for the diagnosis, prevention and management of cryptococcal disease in HIV‐infected adults, adolescents and children. Supplement to the 2016 consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection. www.who.int/hiv/pub/guidelines/cryptococcal‐disease/en/ (accessed prior to 25 April 2018). ">WHO 2018</a>), delaying ART for long periods may increase the risk of death or the development of other opportunistic infections (<a href="./references#CD009012-bbs2-0028" title="LundgernJD , BabikerAG , GordinF , EmeryS , GrundB , SharmaS , et al. Initiation of antiretroviral therapy in early asymptomatic HIV infection. New England Journal of Medicine2015;373(9):795‐807. ">Lundgern 2015</a>). </p> </section> <section id="CD009012-sec-0028"> <h3 class="title" id="CD009012-sec-0028">Why it is important to do this review</h3> <p>Studies that have evaluated the impact of timing of ART initiation in cryptococcal meningitis on mortality have, to date, had mixed results. Most cohort studies have shown no association between ART timing and mortality (<a href="./references#CD009012-bbs2-0018" title="Crabtree RamírezB , Caro VegaY , SheperdBE , LeC , TurnerM , FrolaC , et al. Outcomes of HIV‐positive patients with cryptococcal meningitis in the Americas. International Journal of Infectious Diseases2017;63:57‐63. ">Crabtree Ramírez 2017</a>; <a href="./references#CD009012-bbs2-0026" title="IngleSM , MiroJM , FurrerH , JusticeA , SaagMS , ManzardoC , et al. Impact of ART on mortality in cryptococcal meningitis patients: high‐income settings. Conference on Retroviruses and Opportunistic Infections (CROI); 2015 Feb 23‐25; Seattle (WA). San Francisco: CROI Foundation/IAS‐USA, 2015:Poster 837. ">Ingle 2015</a>; <a href="./references#CD009012-bbs2-0008" title="ManosuthiW , ChottanapundS , SungkanuparphS . Mortality rate of early versus deferred initiation of antiretroviral therapy in HIV‐1‐infected patients with cryptococcal meningitis. Journal of Acquired Immune Deficiency Syndromes2008;48(4):508‐9. ">Manosuthi 2008</a>). However, these cohort studies were underpowered and limited by the inherent methodological issues with the cohort study design (<a href="#CD009012-tbl-0002">Table 1</a>). A previous Cochrane Review suggested that there was insufficient evidence in support of either early or delayed initiation of ART (<a href="./references#CD009012-bbs2-0045" title="NjeiB , KongnyuyEJ , KumarS , OkwenMP , SankarMJ , MbuagbawL . Optimal timing for antiretroviral therapy initiation in patients with HIV infection and concurrent cryptococcal meningitis. Cochrane Database of Systematic Reviews2013, Issue 2. [DOI: 10.1002/14651858.CD009012.pub2] ">Njei 2013</a>). </p> <div class="table" id="CD009012-tbl-0002"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Cohort studies evaluating time to ART initiation in cryptococcal meningitis</span></div> <tbody> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Trial ID</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Design</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Location</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Definitions</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Study period</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Duration of follow‐up</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="3" rowspan="1" valign="top"> <p><b>Mortality</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Trial conclusions</b> </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Early</b> </p> <p><b>(n/N)</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Late</b> </p> <p><b>(n/N)</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Association</b> </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD009012-bbs2-0008" title="ManosuthiW , ChottanapundS , SungkanuparphS . Mortality rate of early versus deferred initiation of antiretroviral therapy in HIV‐1‐infected patients with cryptococcal meningitis. Journal of Acquired Immune Deficiency Syndromes2008;48(4):508‐9. ">Manosuthi 2008</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Retrospective cohort</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Thailand</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Early &lt; 1 month; late ≥ 1 month</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2002 to 2006</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1050 patient years</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>9/52</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>46/229</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Adjusted HR 0.833 (95% CI 0.379 to 1.831)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No difference, however underpowered and risks of selection bias and unmeasured confounders</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD009012-bbs2-0018" title="Crabtree RamírezB , Caro VegaY , SheperdBE , LeC , TurnerM , FrolaC , et al. Outcomes of HIV‐positive patients with cryptococcal meningitis in the Americas. International Journal of Infectious Diseases2017;63:57‐63. ">Crabtree Ramírez 2017</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Retrospective cohort</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>USA and Latin America</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Early &lt; 2 weeks; late 2 to 8 weeks</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1985 to 2014</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unknown</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>7/24</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>14/53</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Adjusted OR 1.09 (95% CI 0.44 to 2.67)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No difference, however underpowered and risks of selection bias and unmeasured confounders</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD009012-bbs2-0026" title="IngleSM , MiroJM , FurrerH , JusticeA , SaagMS , ManzardoC , et al. Impact of ART on mortality in cryptococcal meningitis patients: high‐income settings. Conference on Retroviruses and Opportunistic Infections (CROI); 2015 Feb 23‐25; Seattle (WA). San Francisco: CROI Foundation/IAS‐USA, 2015:Poster 837. ">Ingle 2015</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Retrospective cohort (conference abstract)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>North America</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Early ≤ 14 days; late 14 to 56 days since cryptococcal meningitis diagnosis</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1998 to 2009</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unknown</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>7/62</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>7/67</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Crude HR 1.29 (0.68 to 2.43) and adjusted HR 1.30 (0.66 to 2.55)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No association between timing and mortality, however unmeasured confounders and selection bias an issue. </p> <p>Low power to detect a difference</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>Abbreviations: ART: antiretroviral therapy; CI: confidence interval; HR: hazard ratio; OR: odds ratio </p> </div> </div> <p>Determining when ART should be initiated after a diagnosis of cryptococcal meningitis involves balancing the survival benefit conferred by ART against the risk of IRIS. Conflicting data regarding the relationship between the timing of ART for cryptococcal meningitis and the high mortality pose a therapeutic dilemma, and studies to date have had variable results. We aimed to incorporate recent randomized controlled trials and to update the findings from the earlier review by <a href="./references#CD009012-bbs2-0045" title="NjeiB , KongnyuyEJ , KumarS , OkwenMP , SankarMJ , MbuagbawL . Optimal timing for antiretroviral therapy initiation in patients with HIV infection and concurrent cryptococcal meningitis. Cochrane Database of Systematic Reviews2013, Issue 2. [DOI: 10.1002/14651858.CD009012.pub2] ">Njei 2013</a>. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD009012-sec-0029" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD009012-sec-0029"></div> <p>To compare the outcomes of early initiation ART (less than four weeks after starting antifungal treatment) versus delayed initiation of ART (four weeks or more after starting antifungal treatment) in HIV‐positive people with concurrent cryptococcal meningitis. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD009012-sec-0030" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD009012-sec-0030"></div> <section id="CD009012-sec-0031"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD009012-sec-0032"> <h4 class="title">Types of studies</h4> <p>Randomized controlled trials (RCTs).</p> </section> <section id="CD009012-sec-0033"> <h4 class="title">Types of participants</h4> <p>HIV‐positive children, adolescents, and adults with cryptococcal meningitis.</p> </section> <section id="CD009012-sec-0034"> <h4 class="title">Types of interventions</h4> <p>Early initiation of ART (ART initiated within four weeks of starting antifungal treatment) versus delayed initiation of ART (ART initiated at least four weeks after starting antifungal treatment). </p> </section> <section id="CD009012-sec-0035"> <h4 class="title">Types of outcome measures</h4> <section id="CD009012-sec-0036"> <h5 class="title">Primary outcomes</h5> <p> <ul id="CD009012-list-0001"> <li> <p>All‐cause mortality</p> </li> </ul> </p> </section> <section id="CD009012-sec-0037"> <h5 class="title">Secondary outcomes</h5> <p> <ul id="CD009012-list-0002"> <li> <p>Cryptococcal meningitis relapse</p> <ul id="CD009012-list-0003"> <li> <p>Recurrence of cryptococcal meningitis symptoms in previously laboratory‐confirmed episode of cryptococcal meningitis, with resolution of symptoms for one month after treatment with participants being adherent to antifungal therapy, and now presenting with CSF antigen test or culture positive for <i>C neoformans</i>. </p> </li> </ul> </li> <li> <p>CSF fungal clearance</p> </li> <li> <p>Mortality hazard ratio (HR)</p> </li> <li> <p>Paradoxical cryptococcal IRIS</p> <ul id="CD009012-list-0004"> <li> <p>Fulfilling the <a href="./references#CD009012-bbs2-0023" title="HaddowLJ , ColebundersR , MeintjesG , LawnSD , ElliottJH , ManabeYC , et al. Cryptococcal immune reconstitution inflammatory syndrome in HIV‐1‐infected individuals: proposed clinical case definitions. Lancet Infectious Diseases2010;10(11):791‐802. ">Haddow 2010</a> case definition </p> </li> </ul> </li> <li> <p>HIV virological suppression at six months</p> </li> <li> <p>Length of hospital stay</p> </li> <li> <p>Adverse events</p> <ul id="CD009012-list-0005"> <li> <p>Clinical adverse events</p> </li> <li> <p>Laboratory adverse events</p> </li> <li> <p>Other adverse events</p> </li> </ul> </li> </ul> </p> </section> </section> </section> <section id="CD009012-sec-0038"> <h3 class="title">Search methods for identification of studies</h3> <p>We identified all relevant trials regardless of language or publication status.</p> <section id="CD009012-sec-0039"> <h4 class="title">Electronic searches</h4> <p>We searched the following databases:</p> <section id="CD009012-sec-0040"> <h5 class="title">Routine databases</h5> <p> <ul id="CD009012-list-0006"> <li> <p>Cochrane Central Register of Controlled Trials (CENTRAL): Issue 7 of 12, July 2017, search date 7 August 2017 </p> </li> <li> <p>MEDLINE; search date 7 August 2017 (<a href="./appendices#CD009012-sec-0118">Appendix 1</a>) </p> </li> <li> <p>Embase; search date 7 August 2017 (<a href="./appendices#CD009012-sec-0119">Appendix 2</a>) </p> </li> </ul> </p> </section> <section id="CD009012-sec-0041"> <h5 class="title">International trial registries</h5> <p> <ul id="CD009012-list-0007"> <li> <p>US National Institutes of Health Ongoing Trials Register ClinicalTrials.gov (<a href="http://www.clinicaltrials.gov" target="_blank">www.clinicaltrials.gov</a>), searched on 7 August 2017 </p> </li> <li> <p>WHO International Clinical Trials Registry Platform (ICTRP) (<a href="http://apps.who.int/trialsearch/" target="_blank">apps.who.int/trialsearch</a>), searched on 7 August 2017 </p> </li> </ul> </p> </section> </section> <section id="CD009012-sec-0042"> <h4 class="title">Searching other resources</h4> <section id="CD009012-sec-0043"> <h5 class="title">Conference proceedings</h5> <p> <ul id="CD009012-list-0008"> <li> <p>International AIDS Society (IAS) conference abstracts (2015 to 2017) (<a href="http://www.iasociety.org/" target="_blank">www.iasociety.org</a>) </p> </li> <li> <p>Conference on Retroviruses and Opportunistic Infections (CROI) (2015 to 2017) (<a href="http://www.croiconference.org/" target="_blank">www.croiconference.org/</a>) </p> </li> </ul> </p> </section> <section id="CD009012-sec-0044"> <h5 class="title">Other sources</h5> <p>We checked the reference lists of existing reviews and all trials identified for other potentially relevant trials. </p> </section> </section> </section> <section id="CD009012-sec-0045"> <h3 class="title" id="CD009012-sec-0045">Data collection and analysis</h3> <p>We conducted data collection and analysis following methods recommended in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> and the Methodological Expectations for the Conduct of Cochrane Intervention Reviews (MECIR) (<a href="./references#CD009012-bbs2-0024" title="HigginsJP , GreenS , editor(s) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. Available from handbook.cochrane.org: The Cochrane Collaboration. ">Higgins 2011</a>; <a href="./references#CD009012-bbs2-0025" title="HigginsJPT , LassersonT , ChandlerJ , ToveyD , ChurchillR . Standards for the conduct of new Cochrane Intervention Reviews. In: Higgins JPT, Lasserson T, Chandler J, Tovey D, Churchill R. Methodological Expectations of Cochrane Intervention Reviews. London: The Cochrane Library, 2016. ">Higgins 2016</a>). </p> <section id="CD009012-sec-0046"> <h4 class="title">Selection of studies</h4> <p>Two review authors (MPO and IEW) independently screened the titles and abstracts of all citations identified by searches against our inclusion criteria based on types of studies, interventions, participants, and outcomes. Both review authors evaluated the full‐text articles for inclusion. Where there was uncertainty about the inclusion of a trial, we consulted a third review author (TB). </p> </section> <section id="CD009012-sec-0047"> <h4 class="title">Data extraction and management</h4> <p>We piloted and then finalized a data extraction tool. Two review authors (MPO and IEW) independently completed data extraction for the included trials and discussed discrepancies. In case of disagreement, we consulted a third review author (TB). </p> <p>For dichotomous outcomes, we extracted the number of participants who experienced the event and the number of participants randomized to each treatment group. For time‐to‐event outcomes, we extracted HRs and confidence intervals (CIs). </p> </section> <section id="CD009012-sec-0048"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>Two review authors (MPO and IEW) independently assessed the risk of bias for each trial using the Cochrane ‘Risk of bias’ assessment tool (<a href="./references#CD009012-bbs2-0024" title="HigginsJP , GreenS , editor(s) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. Available from handbook.cochrane.org: The Cochrane Collaboration. ">Higgins 2011</a>). We contacted trial authors for missing information or clarification, but did not receive any responses to these queries. Two review authors independently applied the ‘Risk of bias’ criteria to each trial, resolving any differences in opinion through discussion or by consulting a third review author (MR). We assessed the risk of bias across six domains: sequence generation, allocation concealment, blinding, incomplete outcome data, selective outcome reporting, and other potential biases (<a href="./references#CD009012-bbs2-0024" title="HigginsJP , GreenS , editor(s) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. Available from handbook.cochrane.org: The Cochrane Collaboration. ">Higgins 2011</a>). For each domain, we assigned a judgement of either low, high, or unclear risk of bias. </p> </section> <section id="CD009012-sec-0049"> <h4 class="title">Measures of treatment effect</h4> <p>We presented dichotomous data using risk ratios (RR) with 95% CIs. We used intention‐to‐treat analyses for all dichotomous data. We presented time‐to‐event data using HRs with CIs. </p> </section> <section id="CD009012-sec-0050"> <h4 class="title">Unit of analysis issues</h4> <p>No cluster‐RCTs or trials with more than one intervention arm met the inclusion criteria of this review. </p> </section> <section id="CD009012-sec-0051"> <h4 class="title">Dealing with missing data</h4> <p>Where a trial publication provided insufficient data, we contacted the trial authors to request the additional data (<a href="./references#CD009012-bbs2-0001" title="BissonGP , MolefiM , BellamyS , ThakurR , SteenhoffA , TamuhlaN , et al. Early versus delayed antiretroviral therapy and cerebrospinal fluid fungal clearance in adults with HIV and cryptococcal meningitis. Clinical Infectious Diseases2013;56(8):1165‐73. [DOI: 10.1093/cid/cit019; CN‐00861211] ">Bisson 2013</a>; <a href="./references#CD009012-bbs2-0003" title="MakadzangeAT , NdhlovuCE , TakarindaK , ReidM , KurangwaM , GonaP , et al. Early versus delayed initiation of antiretroviral therapy for concurrent HIV infection and cryptococcal meningitis in sub‐Saharan Africa. Clinical Infectious Diseases2010;50(11):1532‐8. [DOI: 10.1086/652652; CN‐00748368] ">Makadzange 2010</a>). For analyses with persistent missing data, we used available‐case analysis and examined the robustness of this approach by examining best‐ and worse‐case scenarios. <a href="./references#CD009012-bbs2-0001" title="BissonGP , MolefiM , BellamyS , ThakurR , SteenhoffA , TamuhlaN , et al. Early versus delayed antiretroviral therapy and cerebrospinal fluid fungal clearance in adults with HIV and cryptococcal meningitis. Clinical Infectious Diseases2013;56(8):1165‐73. [DOI: 10.1093/cid/cit019; CN‐00861211] ">Bisson 2013</a> provided an HR with 95% CI that was not available in the published manuscript; the method the authors used to generate this HR is uncertain. </p> </section> <section id="CD009012-sec-0052"> <h4 class="title">Assessment of heterogeneity</h4> <p>We assessed the degree of heterogeneity by a visual inspection of forest plots and by examining the Chi<sup>2</sup> test. </p> <p>We quantified the extent of heterogeneity by calculating an estimation of the I<sup>2</sup> statistic. We followed the guidance outlined in Section 9.5.2 of the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD009012-bbs2-0024" title="HigginsJP , GreenS , editor(s) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. Available from handbook.cochrane.org: The Cochrane Collaboration. ">Higgins 2011</a>). </p> <p> <ul id="CD009012-list-0009"> <li> <p>0% to 40%: might not be important</p> </li> <li> <p>30% to 60%: may represent moderate heterogeneity</p> </li> <li> <p>50% to 90%: may represent substantial heterogeneity</p> </li> <li> <p>75% to 100%: considerable heterogeneity</p> </li> </ul> </p> <p>Where heterogeneity was present in pooled effect estimates, we explored possible reasons for variability by conducting subgroup analyses. Due to the limited number of trials and participants contributing to each outcome, we were restricted in the number of subgroup analyses we could conduct. </p> </section> <section id="CD009012-sec-0053"> <h4 class="title">Assessment of reporting biases</h4> <p>We assessed publication bias qualitatively based on the characteristics of the included trials. There were insufficient trials to construct a funnel plot. </p> </section> <section id="CD009012-sec-0054"> <h4 class="title">Data synthesis</h4> <p>We performed analyses using Review Manager 5 (<a href="./references#CD009012-bbs2-0036" title="Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager 5 (RevMan 5). Version 5.3. Copenhagen: Nordic Cochrane Centre, The Cochrane Collaboration, 2014. ">RevMan 2014</a>). When trials were considered clinically and methodologically comparable, we conducted meta‐analyses using a random‐effects model. We presented narrative results of outcomes only if there was insufficient data for a meta‐analysis. For time‐to‐event data, we used HRs and CIs to generate log HRs and standard errors and used the generic inverse‐variance method to analyse these data. </p> <section id="CD009012-sec-0055"> <h5 class="title">Certainty of the evidence</h5> <p>We assessed the certainty of the evidence for each outcome using the GRADE approach (<a href="./references#CD009012-bbs2-0021" title="GuyattGH , OxmanAD , VistGE , KunzR , Falck‐Ytter , Alonso‐CoelloP , et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ2008;336(7650):924‐6. ">Guyatt 2008</a>), which defines the certainty of the evidence for each outcome as “the extent to which one can be confident that an estimate of effect or association is close to the quantity of specific interest” (<a href="./references#CD009012-bbs2-0024" title="HigginsJP , GreenS , editor(s) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. Available from handbook.cochrane.org: The Cochrane Collaboration. ">Higgins 2011</a>). The GRADE certainty rating has four levels: high, moderate, low, or very low. We initially categorized RCTs as high‐certainty evidence, and downgraded the certainty of the evidence after assessment of five criteria: risk of bias, consistency, directness, imprecision, and publication bias (<a href="./references#CD009012-bbs2-0022" title="GuyattG , OxmanAD , AklEA , KunzR , VistG , BrozekJ , et al. GRADE guidelines: 1. Introduction ‐ GRADE evidence profiles and summary of findings tables. Journal of Clinical Epidemiology2011;64(4):383‐94. [DOI: 10.1016/j.jclinepi.2010.04.026] ">Guyatt 2011</a>). Two review authors (IEW and MPO) independently performed this assessment, resolving any disagreements by discussion. </p> <p>We constructed ‘Summary of findings' tables and GRADE evidence tables to present the results of primary and secondary outcomes. We used GRADEpro GDT software to generate the ‘Summary of findings' tables (<a href="./references#CD009012-bbs2-0019" title="McMaster University (developed by Evidence Prime, Inc.). GRADEpro GDT. Version accessed 16 July 2017. Hamilton (ON): McMaster University (developed by Evidence Prime, Inc.), 2015. ">GRADEpro GDT 2015</a>). </p> </section> </section> <section id="CD009012-sec-0056"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>We had initially intended to conduct subgroup analyses for the primary outcome to investigate heterogeneity produced by antifungal drug treatment, geographical region, Glasgow coma score at randomization, and CSF white blood cell count. Due to limited data, we only conducted a subgroup analysis by antifungal drug treatment. </p> </section> <section id="CD009012-sec-0057"> <h4 class="title">Sensitivity analysis</h4> <p>We used sensitivity analyses to assess the robustness of results. Where data were missing, we assessed best‐ and worst‐case scenarios to determine the possible impact of missing data on the overall effect estimates. For the cryptococcal IRIS outcome, those participants who died in the early ART and delayed ART groups may not have been missing completely at random, therefore the assumption in the main analysis (available‐case analysis) may be flawed. In addition, using an intention‐to‐treat analysis would suggest that all those who died would not have developed IRIS. We therefore conducted sensitivity analyses to determine the influence of different risks for IRIS among those who died before they could have received ART or developed IRIS. To evaluate this, we applied a best‐case scenario (8% of those who died in the early ART group would have developed IRIS and 46% of those who died in the delayed ART group would have developed IRIS) and a worst‐case scenario (46% of those who died in the early ART group would have developed IRIS and 8% of those who died in the delayed ART group would have developed IRIS). This was based on the range of reported incidence (8% to 46%) of paradoxical cryptococcal IRIS (<a href="./references#CD009012-bbs2-0023" title="HaddowLJ , ColebundersR , MeintjesG , LawnSD , ElliottJH , ManabeYC , et al. Cryptococcal immune reconstitution inflammatory syndrome in HIV‐1‐infected individuals: proposed clinical case definitions. Lancet Infectious Diseases2010;10(11):791‐802. ">Haddow 2010</a>). </p> <p>Viral load results were only available for a subset of participants in the two trials that reported on this outcome. For our current analysis we assumed these participants to be missing completely at random, however it is possible that participants who died before they received ART or who did not have viral load measurements done despite receiving ART differed from those who had results. We applied best‐ and worst‐case scenarios to these estimates to examine our results. These estimates were based on the range of viral load suppression rates (50% to 89%) reported by Joint United Nations Programme on HIV/AIDS (UNAIDS) for Eastern and sub‐Saharan Africa (<a href="./references#CD009012-bbs2-0039" title="Joint United Nations Programme on HIV/AIDS (UNAIDS). UNAIDS global AIDS update. www.unaids.org/sites/default/files/media_asset/20170720_Data_book_2017_en.pdf (accessed prior to 1 September 2017). ">UNAIDS 2017</a>). </p> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD009012-sec-0058" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD009012-sec-0058"></div> <section id="CD009012-sec-0059"> <h3 class="title">Description of studies</h3> <p>Four trials met the inclusion criteria for this review (<a href="./references#CD009012-bbs2-0001" title="BissonGP , MolefiM , BellamyS , ThakurR , SteenhoffA , TamuhlaN , et al. Early versus delayed antiretroviral therapy and cerebrospinal fluid fungal clearance in adults with HIV and cryptococcal meningitis. Clinical Infectious Diseases2013;56(8):1165‐73. [DOI: 10.1093/cid/cit019; CN‐00861211] ">Bisson 2013</a>; <a href="./references#CD009012-bbs2-0002" title="BoulwareDR , MeyaDB , MuzooraC , RolfesMA , Huppler HullsiekK , MusubireA , et al. Timing of antiretroviral therapy after diagnosis of cryptococcal meningitis. New England Journal of Medicine2014;370(26):2487‐98. [DOI: 10.1056/NEJMoa1312884; CN‐00994166] ">Boulware 2014</a>; <a href="./references#CD009012-bbs2-0003" title="MakadzangeAT , NdhlovuCE , TakarindaK , ReidM , KurangwaM , GonaP , et al. Early versus delayed initiation of antiretroviral therapy for concurrent HIV infection and cryptococcal meningitis in sub‐Saharan Africa. Clinical Infectious Diseases2010;50(11):1532‐8. [DOI: 10.1086/652652; CN‐00748368] ">Makadzange 2010</a>; <a href="./references#CD009012-bbs2-0004" title="ZolopaA , AndersenJ , PowderlyW , SanchezA , SanneI , SuckowC , et al. Early antiretroviral therapy reduces AIDS progression/death in individuals with acute opportunistic infections: a multicenter randomized strategy trial. PLoS ONE2009;4(5):e5575. [DOI: 10.1371/journal.pone.0005575; CN‐00702077] ">Zolopa 2009</a>). See <a href="#CD009012-tbl-0003">Table 2</a>, the ‘<a href="./references#CD009012-sec-0128" title="">Characteristics of included studies</a>' tables, and the ‘<a href="./references#CD009012-sec-0129" title="">Characteristics of excluded studies</a>' tables for trial details. </p> <div class="table" id="CD009012-tbl-0003"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Summary of included studies</span></div> <tbody> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Trial ID</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Country</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Randomized</b> </p> <p><b>(N)</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Male (N; %)</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Age (median; IQR or mean; SD)</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Duration of antifungal therapy prior to randomization</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Antifungal regimen</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p><b>Time to ART initiation after randomization</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>ART regimen<sup>1</sup> </b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Dropouts (N)</b> </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Early</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Delayed</b> </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD009012-bbs2-0001" title="BissonGP , MolefiM , BellamyS , ThakurR , SteenhoffA , TamuhlaN , et al. Early versus delayed antiretroviral therapy and cerebrospinal fluid fungal clearance in adults with HIV and cryptococcal meningitis. Clinical Infectious Diseases2013;56(8):1165‐73. [DOI: 10.1093/cid/cit019; CN‐00861211] ">Bisson 2013</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Botswana</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>28</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>14; 50</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>35 (32 to 41)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>72 hrs</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Amphotericin B and fluconazole</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>7 days (range 5 to 10)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>32 days (range 28 to 36)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>TDF/FTC/EFV or NVP</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD009012-bbs2-0002" title="BoulwareDR , MeyaDB , MuzooraC , RolfesMA , Huppler HullsiekK , MusubireA , et al. Timing of antiretroviral therapy after diagnosis of cryptococcal meningitis. New England Journal of Medicine2014;370(26):2487‐98. [DOI: 10.1056/NEJMoa1312884; CN‐00994166] ">Boulware 2014</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Uganda, South Africa</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>177</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>93; 53</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>35 (28 to 40) early;</p> <p>36 (30 to 40) delayed</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>7 to 11 days</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Amphotericin B and fluconazole</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 to 2 weeks after diagnosis</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5 weeks after diagnosis</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>AZT/3TC/ EFV (80%),</p> <p>D4T/3TC/EFV (19%),</p> <p>TDF/3TC/EFV (1%)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD009012-bbs2-0003" title="MakadzangeAT , NdhlovuCE , TakarindaK , ReidM , KurangwaM , GonaP , et al. Early versus delayed initiation of antiretroviral therapy for concurrent HIV infection and cryptococcal meningitis in sub‐Saharan Africa. Clinical Infectious Diseases2010;50(11):1532‐8. [DOI: 10.1086/652652; CN‐00748368] ">Makadzange 2010</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Zimbabwe</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>54</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>28; 52</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>37 (SD 8.5) early;</p> <p>38 (SD 6.9) delayed</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0 days</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Fluconazole</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>72 hours</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>10 weeks</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>D4T/3TC/ NVP</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD009012-bbs2-0004" title="ZolopaA , AndersenJ , PowderlyW , SanchezA , SanneI , SuckowC , et al. Early antiretroviral therapy reduces AIDS progression/death in individuals with acute opportunistic infections: a multicenter randomized strategy trial. PLoS ONE2009;4(5):e5575. [DOI: 10.1371/journal.pone.0005575; CN‐00702077] ">Zolopa 2009</a><sup>2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>USA, Puerto Rico, South Africa</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>35</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NR</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NR</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>≤ 14 days</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NR</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>48 hours</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6 to 12 weeks</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NNRTI or PI + 2 NRTIs (3TC or FTC)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NR</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>Abbreviations: IQR: interquartile range; N: number of participants; NR: not reported; SD: standard deviation; AZT: Zidovudine; D4T: Stavudine </p> <p><sup>1</sup>TDF: tenofovir; FTC: emtricitabine; EFV: efavirenz; NVP: nevirapine; 3TC: lamivudine; NNRTI: non‐nucleoside reverse transcriptase inhibitor; NRTI: nucleoside reverse transcriptase inhibitor; PI: protease inhibitor.<br/> <sup>2</sup>This trial reported results for participants with a variety of opportunistic infections and did not provide descriptive data specifically for those with cryptococcal meningitis. </p> </div> </div> <section id="CD009012-sec-0060"> <h4 class="title">Results of the search</h4> <p>We searched for trials published between 1 January 1980 and 7 August 2017. The search results are presented in a PRISMA flow diagram (<a href="#CD009012-fig-0001">Figure 1</a>). The electronic searches identified 314 titles and abstracts (80 from clinical trial registries, 180 from routine databases, and 54 from conference abstracts). After de‐duplication, 273 records underwent title and abstract screening. We identified 13 records for full‐text eligibility screening. We excluded seven of these records with reasons (two further duplicates, two journal correspondence, three wrong study design). We included six records representing four trials in the qualitative and quantitative synthesis. </p> <div class="figure" id="CD009012-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Study flow diagram." data-id="CD009012-fig-0001" src="/cdsr/doi/10.1002/14651858.CD009012.pub3/media/CDSR/CD009012/image_n/nCD009012-AFig-FIG01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p> Study flow diagram.</p> </div> </div> </div> </section> <section id="CD009012-sec-0061"> <h4 class="title">Included studies</h4> <p>We have provided a summary of the included trials in <a href="#CD009012-tbl-0003">Table 2</a> and further individual trial details in the ‘<a href="./references#CD009012-sec-0128" title="">Characteristics of included studies</a>' tables. </p> <section id="CD009012-sec-0062"> <h5 class="title">Participants</h5> <p>The <a href="./references#CD009012-bbs2-0004" title="ZolopaA , AndersenJ , PowderlyW , SanchezA , SanneI , SuckowC , et al. Early antiretroviral therapy reduces AIDS progression/death in individuals with acute opportunistic infections: a multicenter randomized strategy trial. PLoS ONE2009;4(5):e5575. [DOI: 10.1371/journal.pone.0005575; CN‐00702077] ">Zolopa 2009</a> trial included participants with several different types of opportunistic infections and did not disaggregate information for those with cryptococcal meningitis, therefore limited descriptive data could be provided for this trial. </p> </section> <section id="CD009012-sec-0063"> <h5 class="title">Setting</h5> <p>We included four trials with 294 participants from Botswana, Puerto Rico, South Africa, Uganda, the USA, and Zimbabwe. Trials were conducted between May 2003 and November 2011. </p> </section> <section id="CD009012-sec-0064"> <h5 class="title">Demographic characteristics</h5> <p>We did not identify any studies conducted in children less than 13 years old. Most trials included only adults aged more than 18 or 21 years, except <a href="./references#CD009012-bbs2-0004" title="ZolopaA , AndersenJ , PowderlyW , SanchezA , SanneI , SuckowC , et al. Early antiretroviral therapy reduces AIDS progression/death in individuals with acute opportunistic infections: a multicenter randomized strategy trial. PLoS ONE2009;4(5):e5575. [DOI: 10.1371/journal.pone.0005575; CN‐00702077] ">Zolopa 2009</a>, which also included adolescents aged 13 years and over. Approximately 50% of participants were male in <a href="./references#CD009012-bbs2-0002" title="BoulwareDR , MeyaDB , MuzooraC , RolfesMA , Huppler HullsiekK , MusubireA , et al. Timing of antiretroviral therapy after diagnosis of cryptococcal meningitis. New England Journal of Medicine2014;370(26):2487‐98. [DOI: 10.1056/NEJMoa1312884; CN‐00994166] ">Boulware 2014</a>, <a href="./references#CD009012-bbs2-0001" title="BissonGP , MolefiM , BellamyS , ThakurR , SteenhoffA , TamuhlaN , et al. Early versus delayed antiretroviral therapy and cerebrospinal fluid fungal clearance in adults with HIV and cryptococcal meningitis. Clinical Infectious Diseases2013;56(8):1165‐73. [DOI: 10.1093/cid/cit019; CN‐00861211] ">Bisson 2013</a>, and <a href="./references#CD009012-bbs2-0003" title="MakadzangeAT , NdhlovuCE , TakarindaK , ReidM , KurangwaM , GonaP , et al. Early versus delayed initiation of antiretroviral therapy for concurrent HIV infection and cryptococcal meningitis in sub‐Saharan Africa. Clinical Infectious Diseases2010;50(11):1532‐8. [DOI: 10.1086/652652; CN‐00748368] ">Makadzange 2010</a>. The median or mean age ranged from 35 to 38 years. </p> </section> <section id="CD009012-sec-0065"> <h5 class="title">HIV illness</h5> <p>All trials included participants who were HIV‐positive and had a diagnosis of cryptococcal meningitis or other opportunistic infection (<a href="./references#CD009012-bbs2-0004" title="ZolopaA , AndersenJ , PowderlyW , SanchezA , SanneI , SuckowC , et al. Early antiretroviral therapy reduces AIDS progression/death in individuals with acute opportunistic infections: a multicenter randomized strategy trial. PLoS ONE2009;4(5):e5575. [DOI: 10.1371/journal.pone.0005575; CN‐00702077] ">Zolopa 2009</a>). </p> </section> <section id="CD009012-sec-0066"> <h5 class="title">Exclusion criteria</h5> <p>Previous or current ART use was an exclusion criterion for all trials. All trials except <a href="./references#CD009012-bbs2-0004" title="ZolopaA , AndersenJ , PowderlyW , SanchezA , SanneI , SuckowC , et al. Early antiretroviral therapy reduces AIDS progression/death in individuals with acute opportunistic infections: a multicenter randomized strategy trial. PLoS ONE2009;4(5):e5575. [DOI: 10.1371/journal.pone.0005575; CN‐00702077] ">Zolopa 2009</a> further excluded pregnancy/lactation and concurrent central nervous system infections such as bacterial meningitis. </p> </section> <section id="CD009012-sec-0067"> <h5 class="title">Intervention and comparison</h5> <section id="CD009012-sec-0068"> <h6 class="title">Antifungal therapy</h6> <p>Antifungal treatment regimens differed markedly between trials. Two trials used a combination of amphotericin B and fluconazole in the induction and consolidation antifungal regimen (<a href="./references#CD009012-bbs2-0001" title="BissonGP , MolefiM , BellamyS , ThakurR , SteenhoffA , TamuhlaN , et al. Early versus delayed antiretroviral therapy and cerebrospinal fluid fungal clearance in adults with HIV and cryptococcal meningitis. Clinical Infectious Diseases2013;56(8):1165‐73. [DOI: 10.1093/cid/cit019; CN‐00861211] ">Bisson 2013</a>; <a href="./references#CD009012-bbs2-0002" title="BoulwareDR , MeyaDB , MuzooraC , RolfesMA , Huppler HullsiekK , MusubireA , et al. Timing of antiretroviral therapy after diagnosis of cryptococcal meningitis. New England Journal of Medicine2014;370(26):2487‐98. [DOI: 10.1056/NEJMoa1312884; CN‐00994166] ">Boulware 2014</a>); one trial used fluconazole only (<a href="./references#CD009012-bbs2-0003" title="MakadzangeAT , NdhlovuCE , TakarindaK , ReidM , KurangwaM , GonaP , et al. Early versus delayed initiation of antiretroviral therapy for concurrent HIV infection and cryptococcal meningitis in sub‐Saharan Africa. Clinical Infectious Diseases2010;50(11):1532‐8. [DOI: 10.1086/652652; CN‐00748368] ">Makadzange 2010</a>); and one trial did not report on the antifungal regimen (<a href="./references#CD009012-bbs2-0004" title="ZolopaA , AndersenJ , PowderlyW , SanchezA , SanneI , SuckowC , et al. Early antiretroviral therapy reduces AIDS progression/death in individuals with acute opportunistic infections: a multicenter randomized strategy trial. PLoS ONE2009;4(5):e5575. [DOI: 10.1371/journal.pone.0005575; CN‐00702077] ">Zolopa 2009</a>). <a href="./references#CD009012-bbs2-0001" title="BissonGP , MolefiM , BellamyS , ThakurR , SteenhoffA , TamuhlaN , et al. Early versus delayed antiretroviral therapy and cerebrospinal fluid fungal clearance in adults with HIV and cryptococcal meningitis. Clinical Infectious Diseases2013;56(8):1165‐73. [DOI: 10.1093/cid/cit019; CN‐00861211] ">Bisson 2013</a> provided amphotericin B (0.7 mg/kg/day) for two weeks, followed by oral fluconazole 400 mg daily for eight weeks. <a href="./references#CD009012-bbs2-0002" title="BoulwareDR , MeyaDB , MuzooraC , RolfesMA , Huppler HullsiekK , MusubireA , et al. Timing of antiretroviral therapy after diagnosis of cryptococcal meningitis. New England Journal of Medicine2014;370(26):2487‐98. [DOI: 10.1056/NEJMoa1312884; CN‐00994166] ">Boulware 2014</a> administered two weeks of amphotericin B (0.7 to 1.0 mg/kg/day) combined with fluconazole (800 mg/day) followed by 800 mg of fluconazole per day for at least three weeks or until a CSF culture was sterile, followed by 400 mg of fluconazole per day thereafter, for a total consolidation period of at least 12 weeks. <a href="./references#CD009012-bbs2-0003" title="MakadzangeAT , NdhlovuCE , TakarindaK , ReidM , KurangwaM , GonaP , et al. Early versus delayed initiation of antiretroviral therapy for concurrent HIV infection and cryptococcal meningitis in sub‐Saharan Africa. Clinical Infectious Diseases2010;50(11):1532‐8. [DOI: 10.1086/652652; CN‐00748368] ">Makadzange 2010</a> used fluconazole 800 mg daily for 10 weeks. These three trials also reported prescribing secondary prophylaxis of 200 mg of fluconazole per day after the induction and consolidation phases of antifungal treatment. </p> <p><a href="./references#CD009012-bbs2-0002" title="BoulwareDR , MeyaDB , MuzooraC , RolfesMA , Huppler HullsiekK , MusubireA , et al. Timing of antiretroviral therapy after diagnosis of cryptococcal meningitis. New England Journal of Medicine2014;370(26):2487‐98. [DOI: 10.1056/NEJMoa1312884; CN‐00994166] ">Boulware 2014</a> reported that participants received between 7 and 11 days of antifungal therapy prior to randomization, and <a href="./references#CD009012-bbs2-0004" title="ZolopaA , AndersenJ , PowderlyW , SanchezA , SanneI , SuckowC , et al. Early antiretroviral therapy reduces AIDS progression/death in individuals with acute opportunistic infections: a multicenter randomized strategy trial. PLoS ONE2009;4(5):e5575. [DOI: 10.1371/journal.pone.0005575; CN‐00702077] ">Zolopa 2009</a> also allowed for ≤ 14 days of antifungal treatment prior to randomization for ART initiation. <a href="./references#CD009012-bbs2-0001" title="BissonGP , MolefiM , BellamyS , ThakurR , SteenhoffA , TamuhlaN , et al. Early versus delayed antiretroviral therapy and cerebrospinal fluid fungal clearance in adults with HIV and cryptococcal meningitis. Clinical Infectious Diseases2013;56(8):1165‐73. [DOI: 10.1093/cid/cit019; CN‐00861211] ">Bisson 2013</a> randomized participants within 72 hours of antifungal therapy initiation, and <a href="./references#CD009012-bbs2-0003" title="MakadzangeAT , NdhlovuCE , TakarindaK , ReidM , KurangwaM , GonaP , et al. Early versus delayed initiation of antiretroviral therapy for concurrent HIV infection and cryptococcal meningitis in sub‐Saharan Africa. Clinical Infectious Diseases2010;50(11):1532‐8. [DOI: 10.1086/652652; CN‐00748368] ">Makadzange 2010</a> randomized participants at the time of cryptococcal meningitis diagnosis. Only one trial described providing supportive care in the form of electrolyte replacement, fluid management, and routine therapeutic lumbar punctures (<a href="./references#CD009012-bbs2-0002" title="BoulwareDR , MeyaDB , MuzooraC , RolfesMA , Huppler HullsiekK , MusubireA , et al. Timing of antiretroviral therapy after diagnosis of cryptococcal meningitis. New England Journal of Medicine2014;370(26):2487‐98. [DOI: 10.1056/NEJMoa1312884; CN‐00994166] ">Boulware 2014</a>). </p> </section> <section id="CD009012-sec-0069"> <h6 class="title">Antiretroviral therapy</h6> <p>Three trials reported using a combination of two nucleoside reverse transcriptase inhibitors including tenofovir, emtricitabine, zidovudine, and stavudine, and one non‐nucleoside reverse transcriptase inhibitor, either efavirenz or nevirapine (<a href="./references#CD009012-bbs2-0001" title="BissonGP , MolefiM , BellamyS , ThakurR , SteenhoffA , TamuhlaN , et al. Early versus delayed antiretroviral therapy and cerebrospinal fluid fungal clearance in adults with HIV and cryptococcal meningitis. Clinical Infectious Diseases2013;56(8):1165‐73. [DOI: 10.1093/cid/cit019; CN‐00861211] ">Bisson 2013</a>; <a href="./references#CD009012-bbs2-0002" title="BoulwareDR , MeyaDB , MuzooraC , RolfesMA , Huppler HullsiekK , MusubireA , et al. Timing of antiretroviral therapy after diagnosis of cryptococcal meningitis. New England Journal of Medicine2014;370(26):2487‐98. [DOI: 10.1056/NEJMoa1312884; CN‐00994166] ">Boulware 2014</a>; <a href="./references#CD009012-bbs2-0003" title="MakadzangeAT , NdhlovuCE , TakarindaK , ReidM , KurangwaM , GonaP , et al. Early versus delayed initiation of antiretroviral therapy for concurrent HIV infection and cryptococcal meningitis in sub‐Saharan Africa. Clinical Infectious Diseases2010;50(11):1532‐8. [DOI: 10.1086/652652; CN‐00748368] ">Makadzange 2010</a>), or protease inhibitor (<a href="./references#CD009012-bbs2-0004" title="ZolopaA , AndersenJ , PowderlyW , SanchezA , SanneI , SuckowC , et al. Early antiretroviral therapy reduces AIDS progression/death in individuals with acute opportunistic infections: a multicenter randomized strategy trial. PLoS ONE2009;4(5):e5575. [DOI: 10.1371/journal.pone.0005575; CN‐00702077] ">Zolopa 2009</a>). </p> <section id="CD009012-sec-0070"> <p><b>Early ART</b></p> <p>For early initiation of ART, all trials reported starting ART within two weeks of randomization (<a href="./references#CD009012-bbs2-0001" title="BissonGP , MolefiM , BellamyS , ThakurR , SteenhoffA , TamuhlaN , et al. Early versus delayed antiretroviral therapy and cerebrospinal fluid fungal clearance in adults with HIV and cryptococcal meningitis. Clinical Infectious Diseases2013;56(8):1165‐73. [DOI: 10.1093/cid/cit019; CN‐00861211] ">Bisson 2013</a>; <a href="./references#CD009012-bbs2-0002" title="BoulwareDR , MeyaDB , MuzooraC , RolfesMA , Huppler HullsiekK , MusubireA , et al. Timing of antiretroviral therapy after diagnosis of cryptococcal meningitis. New England Journal of Medicine2014;370(26):2487‐98. [DOI: 10.1056/NEJMoa1312884; CN‐00994166] ">Boulware 2014</a>; <a href="./references#CD009012-bbs2-0003" title="MakadzangeAT , NdhlovuCE , TakarindaK , ReidM , KurangwaM , GonaP , et al. Early versus delayed initiation of antiretroviral therapy for concurrent HIV infection and cryptococcal meningitis in sub‐Saharan Africa. Clinical Infectious Diseases2010;50(11):1532‐8. [DOI: 10.1086/652652; CN‐00748368] ">Makadzange 2010</a>), with one trial initiating ART within 5 to 10 days (<a href="./references#CD009012-bbs2-0001" title="BissonGP , MolefiM , BellamyS , ThakurR , SteenhoffA , TamuhlaN , et al. Early versus delayed antiretroviral therapy and cerebrospinal fluid fungal clearance in adults with HIV and cryptococcal meningitis. Clinical Infectious Diseases2013;56(8):1165‐73. [DOI: 10.1093/cid/cit019; CN‐00861211] ">Bisson 2013</a>), another within 1 to 2 weeks (<a href="./references#CD009012-bbs2-0002" title="BoulwareDR , MeyaDB , MuzooraC , RolfesMA , Huppler HullsiekK , MusubireA , et al. Timing of antiretroviral therapy after diagnosis of cryptococcal meningitis. New England Journal of Medicine2014;370(26):2487‐98. [DOI: 10.1056/NEJMoa1312884; CN‐00994166] ">Boulware 2014</a>), and two trials initiating ART within 72 and 48 hours, respectively (<a href="./references#CD009012-bbs2-0003" title="MakadzangeAT , NdhlovuCE , TakarindaK , ReidM , KurangwaM , GonaP , et al. Early versus delayed initiation of antiretroviral therapy for concurrent HIV infection and cryptococcal meningitis in sub‐Saharan Africa. Clinical Infectious Diseases2010;50(11):1532‐8. [DOI: 10.1086/652652; CN‐00748368] ">Makadzange 2010</a>; <a href="./references#CD009012-bbs2-0004" title="ZolopaA , AndersenJ , PowderlyW , SanchezA , SanneI , SuckowC , et al. Early antiretroviral therapy reduces AIDS progression/death in individuals with acute opportunistic infections: a multicenter randomized strategy trial. PLoS ONE2009;4(5):e5575. [DOI: 10.1371/journal.pone.0005575; CN‐00702077] ">Zolopa 2009</a>). </p> </section> <section id="CD009012-sec-0071"> <p><b>Delayed ART</b></p> <p>Two trials reported initiating delayed ART around the one‐month mark: <a href="./references#CD009012-bbs2-0002" title="BoulwareDR , MeyaDB , MuzooraC , RolfesMA , Huppler HullsiekK , MusubireA , et al. Timing of antiretroviral therapy after diagnosis of cryptococcal meningitis. New England Journal of Medicine2014;370(26):2487‐98. [DOI: 10.1056/NEJMoa1312884; CN‐00994166] ">Boulware 2014</a> (five weeks) and <a href="./references#CD009012-bbs2-0001" title="BissonGP , MolefiM , BellamyS , ThakurR , SteenhoffA , TamuhlaN , et al. Early versus delayed antiretroviral therapy and cerebrospinal fluid fungal clearance in adults with HIV and cryptococcal meningitis. Clinical Infectious Diseases2013;56(8):1165‐73. [DOI: 10.1093/cid/cit019; CN‐00861211] ">Bisson 2013</a> (32 days). <a href="./references#CD009012-bbs2-0003" title="MakadzangeAT , NdhlovuCE , TakarindaK , ReidM , KurangwaM , GonaP , et al. Early versus delayed initiation of antiretroviral therapy for concurrent HIV infection and cryptococcal meningitis in sub‐Saharan Africa. Clinical Infectious Diseases2010;50(11):1532‐8. [DOI: 10.1086/652652; CN‐00748368] ">Makadzange 2010</a> initiated delayed ART at a median of 10 weeks, and the delayed group in <a href="./references#CD009012-bbs2-0004" title="ZolopaA , AndersenJ , PowderlyW , SanchezA , SanneI , SuckowC , et al. Early antiretroviral therapy reduces AIDS progression/death in individuals with acute opportunistic infections: a multicenter randomized strategy trial. PLoS ONE2009;4(5):e5575. [DOI: 10.1371/journal.pone.0005575; CN‐00702077] ">Zolopa 2009</a> initiated ART between 6 and 12 weeks after randomization. </p> </section> </section> </section> <section id="CD009012-sec-0072"> <h5 class="title">Outcomes</h5> <p>Three trials reported on all‐cause mortality at 6 to 12 months after randomization; we obtained additional data for this outcome directly from the authors of <a href="./references#CD009012-bbs2-0003" title="MakadzangeAT , NdhlovuCE , TakarindaK , ReidM , KurangwaM , GonaP , et al. Early versus delayed initiation of antiretroviral therapy for concurrent HIV infection and cryptococcal meningitis in sub‐Saharan Africa. Clinical Infectious Diseases2010;50(11):1532‐8. [DOI: 10.1086/652652; CN‐00748368] ">Makadzange 2010</a>. <a href="./references#CD009012-bbs2-0004" title="ZolopaA , AndersenJ , PowderlyW , SanchezA , SanneI , SuckowC , et al. Early antiretroviral therapy reduces AIDS progression/death in individuals with acute opportunistic infections: a multicenter randomized strategy trial. PLoS ONE2009;4(5):e5575. [DOI: 10.1371/journal.pone.0005575; CN‐00702077] ">Zolopa 2009</a> reported 12‐month mortality, while the remaining trials reported six‐month mortality. </p> <p>Only <a href="./references#CD009012-bbs2-0001" title="BissonGP , MolefiM , BellamyS , ThakurR , SteenhoffA , TamuhlaN , et al. Early versus delayed antiretroviral therapy and cerebrospinal fluid fungal clearance in adults with HIV and cryptococcal meningitis. Clinical Infectious Diseases2013;56(8):1165‐73. [DOI: 10.1093/cid/cit019; CN‐00861211] ">Bisson 2013</a> and <a href="./references#CD009012-bbs2-0002" title="BoulwareDR , MeyaDB , MuzooraC , RolfesMA , Huppler HullsiekK , MusubireA , et al. Timing of antiretroviral therapy after diagnosis of cryptococcal meningitis. New England Journal of Medicine2014;370(26):2487‐98. [DOI: 10.1056/NEJMoa1312884; CN‐00994166] ">Boulware 2014</a> reported cryptococcal meningitis relapse, CSF fungal clearance, cryptococcal IRIS, and HIV virological suppression at six months. Cerebrospinal fluid fungal clearance was reported by treatment arm as the rate of fungal clearance by <a href="./references#CD009012-bbs2-0001" title="BissonGP , MolefiM , BellamyS , ThakurR , SteenhoffA , TamuhlaN , et al. Early versus delayed antiretroviral therapy and cerebrospinal fluid fungal clearance in adults with HIV and cryptococcal meningitis. Clinical Infectious Diseases2013;56(8):1165‐73. [DOI: 10.1093/cid/cit019; CN‐00861211] ">Bisson 2013</a> and as the cumulative incidence of CSF culture positivity at 14 days of amphotericin B therapy by <a href="./references#CD009012-bbs2-0002" title="BoulwareDR , MeyaDB , MuzooraC , RolfesMA , Huppler HullsiekK , MusubireA , et al. Timing of antiretroviral therapy after diagnosis of cryptococcal meningitis. New England Journal of Medicine2014;370(26):2487‐98. [DOI: 10.1056/NEJMoa1312884; CN‐00994166] ">Boulware 2014</a>. </p> <p>Three trials presented mortality time‐to‐event data (<a href="./references#CD009012-bbs2-0001" title="BissonGP , MolefiM , BellamyS , ThakurR , SteenhoffA , TamuhlaN , et al. Early versus delayed antiretroviral therapy and cerebrospinal fluid fungal clearance in adults with HIV and cryptococcal meningitis. Clinical Infectious Diseases2013;56(8):1165‐73. [DOI: 10.1093/cid/cit019; CN‐00861211] ">Bisson 2013</a>; <a href="./references#CD009012-bbs2-0002" title="BoulwareDR , MeyaDB , MuzooraC , RolfesMA , Huppler HullsiekK , MusubireA , et al. Timing of antiretroviral therapy after diagnosis of cryptococcal meningitis. New England Journal of Medicine2014;370(26):2487‐98. [DOI: 10.1056/NEJMoa1312884; CN‐00994166] ">Boulware 2014</a>; <a href="./references#CD009012-bbs2-0003" title="MakadzangeAT , NdhlovuCE , TakarindaK , ReidM , KurangwaM , GonaP , et al. Early versus delayed initiation of antiretroviral therapy for concurrent HIV infection and cryptococcal meningitis in sub‐Saharan Africa. Clinical Infectious Diseases2010;50(11):1532‐8. [DOI: 10.1086/652652; CN‐00748368] ">Makadzange 2010</a>). <a href="./references#CD009012-bbs2-0003" title="MakadzangeAT , NdhlovuCE , TakarindaK , ReidM , KurangwaM , GonaP , et al. Early versus delayed initiation of antiretroviral therapy for concurrent HIV infection and cryptococcal meningitis in sub‐Saharan Africa. Clinical Infectious Diseases2010;50(11):1532‐8. [DOI: 10.1086/652652; CN‐00748368] ">Makadzange 2010</a> and <a href="./references#CD009012-bbs2-0002" title="BoulwareDR , MeyaDB , MuzooraC , RolfesMA , Huppler HullsiekK , MusubireA , et al. Timing of antiretroviral therapy after diagnosis of cryptococcal meningitis. New England Journal of Medicine2014;370(26):2487‐98. [DOI: 10.1056/NEJMoa1312884; CN‐00994166] ">Boulware 2014</a> reported unadjusted HRs, while <a href="./references#CD009012-bbs2-0001" title="BissonGP , MolefiM , BellamyS , ThakurR , SteenhoffA , TamuhlaN , et al. Early versus delayed antiretroviral therapy and cerebrospinal fluid fungal clearance in adults with HIV and cryptococcal meningitis. Clinical Infectious Diseases2013;56(8):1165‐73. [DOI: 10.1093/cid/cit019; CN‐00861211] ">Bisson 2013</a> presented a Kaplan Meier survival curve from which the HR was derived (see <a href="#CD009012-sec-0051">Dealing with missing data</a>). </p> <p>No trials reported length of hospital stay as a trial outcome; <a href="./references#CD009012-bbs2-0001" title="BissonGP , MolefiM , BellamyS , ThakurR , SteenhoffA , TamuhlaN , et al. Early versus delayed antiretroviral therapy and cerebrospinal fluid fungal clearance in adults with HIV and cryptococcal meningitis. Clinical Infectious Diseases2013;56(8):1165‐73. [DOI: 10.1093/cid/cit019; CN‐00861211] ">Bisson 2013</a> reported only on prolonged hospitalizations, however this was not defined. </p> <p>Varying details on adverse events were present for all trials except <a href="./references#CD009012-bbs2-0004" title="ZolopaA , AndersenJ , PowderlyW , SanchezA , SanneI , SuckowC , et al. Early antiretroviral therapy reduces AIDS progression/death in individuals with acute opportunistic infections: a multicenter randomized strategy trial. PLoS ONE2009;4(5):e5575. [DOI: 10.1371/journal.pone.0005575; CN‐00702077] ">Zolopa 2009</a>. <a href="./references#CD009012-bbs2-0001" title="BissonGP , MolefiM , BellamyS , ThakurR , SteenhoffA , TamuhlaN , et al. Early versus delayed antiretroviral therapy and cerebrospinal fluid fungal clearance in adults with HIV and cryptococcal meningitis. Clinical Infectious Diseases2013;56(8):1165‐73. [DOI: 10.1093/cid/cit019; CN‐00861211] ">Bisson 2013</a> described at least one grade 3 to 5 Division of AIDS (DAIDS) adverse event, and <a href="./references#CD009012-bbs2-0002" title="BoulwareDR , MeyaDB , MuzooraC , RolfesMA , Huppler HullsiekK , MusubireA , et al. Timing of antiretroviral therapy after diagnosis of cryptococcal meningitis. New England Journal of Medicine2014;370(26):2487‐98. [DOI: 10.1056/NEJMoa1312884; CN‐00994166] ">Boulware 2014</a> described the cumulative incidence of such events, while <a href="./references#CD009012-bbs2-0003" title="MakadzangeAT , NdhlovuCE , TakarindaK , ReidM , KurangwaM , GonaP , et al. Early versus delayed initiation of antiretroviral therapy for concurrent HIV infection and cryptococcal meningitis in sub‐Saharan Africa. Clinical Infectious Diseases2010;50(11):1532‐8. [DOI: 10.1086/652652; CN‐00748368] ">Makadzange 2010</a> gave limited narrative information on adverse events. </p> </section> </section> <section id="CD009012-sec-0073"> <h4 class="title">Excluded studies</h4> <p>We excluded seven publications after full‐text assessment for the reasons described in the ‘<a href="./references#CD009012-sec-0129" title="">Characteristics of excluded studies</a>' tables (<a href="./references#CD009012-bbs2-0005" title="MakadzangeAT , MothobiN . Randomised controlled trial: delaying initiation of ART for 5 weeks improves survival in patients with HIV infection with cryptococcal meningitis. Evidence‐Based Medicine2015;20(1):15. ">Makadzange 2015a</a>; <a href="./references#CD009012-bbs2-0006" title="MakadzangeAT , MothobiN . Delaying initiation of ART for 5 weeks improves survival in patients with HIV infection with cryptococcal meningitis. Evidence‐Based Medicine2015;20(1):15. ">Makadzange 2015b</a>; <a href="./references#CD009012-bbs2-0007" title="MakadzangeAT , MothobiN , IsaacML , LarsonEB , BoulwareDR , MeyaDB , et al. Delaying initiation of ART for 5 weeks improves survival in patients with HIV infection with cryptococcal meningitis. Evidence‐Based Medicine2015;20(1):15. ">Makadzange 2015c</a>; <a href="./references#CD009012-bbs2-0008" title="ManosuthiW , ChottanapundS , SungkanuparphS . Mortality rate of early versus deferred initiation of antiretroviral therapy in HIV‐1‐infected patients with cryptococcal meningitis. Journal of Acquired Immune Deficiency Syndromes2008;48(4):508‐9. ">Manosuthi 2008</a>; <a href="./references#CD009012-bbs2-0009" title="SungkanuparphS , FillerSG , ChetchotisakdP , PappasPG , NolenTL , ManosuthiW , et al. Cryptococcal immune reconstitution inflammatory syndrome after antiretroviral therapy in AIDS patients with cryptococcal meningitis: a prospective multicenter study. Clinical Infectious Diseases2009;49(6):931‐4. ">Sungkanuparph 2009</a>; <a href="./references#CD009012-bbs2-0010" title="SunpathH , EdwinC , ChelinN , NadesanS , MaharajR , MoosaY , et al. Operationalizing early antiretroviral therapy in HIV‐infected in‐patients with opportunistic infections including tuberculosis. International Journal of Tuberculosis and Lung Disease2012;16(7):917‐23. ">Sunpath 2012</a>; <a href="./references#CD009012-bbs2-0011" title="TorokME , DayJN , HienTT , FarrarJJ . Immediate or deferred antiretroviral therapy for central nervous system opportunistic infections?. AIDS2005;19(5):535‐6. ">Torok 2005</a>). </p> </section> </section> <section id="CD009012-sec-0074"> <h3 class="title">Risk of bias in included studies</h3> <p>We evaluated the risk of bias of included trials for each of the six domains (see the ‘<a href="./references#CD009012-sec-0128" title="">Characteristics of included studies</a>' tables). We did a graphical summary of the ‘Risk of bias' assessment as represented in <a href="#CD009012-fig-0002">Figure 2</a> and <a href="#CD009012-fig-0003">Figure 3</a> . </p> <div class="figure" id="CD009012-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="‘Risk of bias' summary: review authors' judgements about each ‘Risk of bias' item for each included trial." data-id="CD009012-fig-0002" src="/cdsr/doi/10.1002/14651858.CD009012.pub3/media/CDSR/CD009012/image_n/nCD009012-AFig-FIG02.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>‘Risk of bias' summary: review authors' judgements about each ‘Risk of bias' item for each included trial. </p> </div> </div> </div> <div class="figure" id="CD009012-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="‘Risk of bias' graph: review authors' judgements about each ‘Risk of bias' item presented as percentages across all included trials." data-id="CD009012-fig-0003" src="/cdsr/doi/10.1002/14651858.CD009012.pub3/media/CDSR/CD009012/image_n/nCD009012-AFig-FIG03.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>‘Risk of bias' graph: review authors' judgements about each ‘Risk of bias' item presented as percentages across all included trials. </p> </div> </div> </div> <section id="CD009012-sec-0075"> <h4 class="title">Allocation</h4> <p>Three of the four included trials adequately described random sequence generation and allocation concealment and were considered free of selection bias (<a href="./references#CD009012-bbs2-0002" title="BoulwareDR , MeyaDB , MuzooraC , RolfesMA , Huppler HullsiekK , MusubireA , et al. Timing of antiretroviral therapy after diagnosis of cryptococcal meningitis. New England Journal of Medicine2014;370(26):2487‐98. [DOI: 10.1056/NEJMoa1312884; CN‐00994166] ">Boulware 2014</a>; <a href="./references#CD009012-bbs2-0003" title="MakadzangeAT , NdhlovuCE , TakarindaK , ReidM , KurangwaM , GonaP , et al. Early versus delayed initiation of antiretroviral therapy for concurrent HIV infection and cryptococcal meningitis in sub‐Saharan Africa. Clinical Infectious Diseases2010;50(11):1532‐8. [DOI: 10.1086/652652; CN‐00748368] ">Makadzange 2010</a>; <a href="./references#CD009012-bbs2-0004" title="ZolopaA , AndersenJ , PowderlyW , SanchezA , SanneI , SuckowC , et al. Early antiretroviral therapy reduces AIDS progression/death in individuals with acute opportunistic infections: a multicenter randomized strategy trial. PLoS ONE2009;4(5):e5575. [DOI: 10.1371/journal.pone.0005575; CN‐00702077] ">Zolopa 2009</a>). One trial had an unclear risk of selection bias for both random sequence generation and allocation concealment, which were inadequately described (<a href="./references#CD009012-bbs2-0001" title="BissonGP , MolefiM , BellamyS , ThakurR , SteenhoffA , TamuhlaN , et al. Early versus delayed antiretroviral therapy and cerebrospinal fluid fungal clearance in adults with HIV and cryptococcal meningitis. Clinical Infectious Diseases2013;56(8):1165‐73. [DOI: 10.1093/cid/cit019; CN‐00861211] ">Bisson 2013</a>). </p> </section> <section id="CD009012-sec-0076"> <h4 class="title">Blinding</h4> <p>All four trials were open‐label trials, that is participants and personnel were not blinded to treatment allocation group; we assessed these trials as having a high risk for performance bias. Outcome assessors were generally not blinded in the included trials for most outcomes. Two trials blinded IRIS outcome assessors (<a href="./references#CD009012-bbs2-0002" title="BoulwareDR , MeyaDB , MuzooraC , RolfesMA , Huppler HullsiekK , MusubireA , et al. Timing of antiretroviral therapy after diagnosis of cryptococcal meningitis. New England Journal of Medicine2014;370(26):2487‐98. [DOI: 10.1056/NEJMoa1312884; CN‐00994166] ">Boulware 2014</a>; <a href="./references#CD009012-bbs2-0004" title="ZolopaA , AndersenJ , PowderlyW , SanchezA , SanneI , SuckowC , et al. Early antiretroviral therapy reduces AIDS progression/death in individuals with acute opportunistic infections: a multicenter randomized strategy trial. PLoS ONE2009;4(5):e5575. [DOI: 10.1371/journal.pone.0005575; CN‐00702077] ">Zolopa 2009</a>). We did not consider blinding an issue for mortality assessment and laboratory results, as these are objective outcomes, however adverse events and IRIS are fairly subjective. As a result, we assessed most trials as having an overall unclear risk of bias for outcome assessment. </p> </section> <section id="CD009012-sec-0077"> <h4 class="title">Incomplete outcome data</h4> <p>The proportion of participants lost to follow‐up was low (&lt; 15%) in all trials. There was also no evidence of differential loss to follow‐up. <a href="./references#CD009012-bbs2-0004" title="ZolopaA , AndersenJ , PowderlyW , SanchezA , SanneI , SuckowC , et al. Early antiretroviral therapy reduces AIDS progression/death in individuals with acute opportunistic infections: a multicenter randomized strategy trial. PLoS ONE2009;4(5):e5575. [DOI: 10.1371/journal.pone.0005575; CN‐00702077] ">Zolopa 2009</a> only reported attrition for the total number of randomized participants and not specifically for those with cryptococcal meningitis; overall approximately 13% of participants were lost follow‐up in this trial. We assessed all trials as at low risk of attrition bias. </p> </section> <section id="CD009012-sec-0078"> <h4 class="title">Selective reporting</h4> <p>Two trials had published protocols that were available for assessment (<a href="./references#CD009012-bbs2-0001" title="BissonGP , MolefiM , BellamyS , ThakurR , SteenhoffA , TamuhlaN , et al. Early versus delayed antiretroviral therapy and cerebrospinal fluid fungal clearance in adults with HIV and cryptococcal meningitis. Clinical Infectious Diseases2013;56(8):1165‐73. [DOI: 10.1093/cid/cit019; CN‐00861211] ">Bisson 2013</a>; <a href="./references#CD009012-bbs2-0002" title="BoulwareDR , MeyaDB , MuzooraC , RolfesMA , Huppler HullsiekK , MusubireA , et al. Timing of antiretroviral therapy after diagnosis of cryptococcal meningitis. New England Journal of Medicine2014;370(26):2487‐98. [DOI: 10.1056/NEJMoa1312884; CN‐00994166] ">Boulware 2014</a>); these trials reported all relevant outcomes and were assessed as at low risk of reporting bias. We classified two trials as at unclear risk of bias for selective outcome reporting: <a href="./references#CD009012-bbs2-0004" title="ZolopaA , AndersenJ , PowderlyW , SanchezA , SanneI , SuckowC , et al. Early antiretroviral therapy reduces AIDS progression/death in individuals with acute opportunistic infections: a multicenter randomized strategy trial. PLoS ONE2009;4(5):e5575. [DOI: 10.1371/journal.pone.0005575; CN‐00702077] ">Zolopa 2009</a> did not have a protocol available for assessment, and the protocol for <a href="./references#CD009012-bbs2-0003" title="MakadzangeAT , NdhlovuCE , TakarindaK , ReidM , KurangwaM , GonaP , et al. Early versus delayed initiation of antiretroviral therapy for concurrent HIV infection and cryptococcal meningitis in sub‐Saharan Africa. Clinical Infectious Diseases2010;50(11):1532‐8. [DOI: 10.1086/652652; CN‐00748368] ">Makadzange 2010</a> was only published after the trial was completed, and no prespecified outcomes were included in the published protocol. </p> </section> <section id="CD009012-sec-0079"> <h4 class="title">Other potential sources of bias</h4> <p>One trial was at high risk of other potential sources of bias (<a href="./references#CD009012-bbs2-0003" title="MakadzangeAT , NdhlovuCE , TakarindaK , ReidM , KurangwaM , GonaP , et al. Early versus delayed initiation of antiretroviral therapy for concurrent HIV infection and cryptococcal meningitis in sub‐Saharan Africa. Clinical Infectious Diseases2010;50(11):1532‐8. [DOI: 10.1086/652652; CN‐00748368] ">Makadzange 2010</a>). Some reported results were not arithmetically correct, which could have had an impact on effect estimates. In addition, the authors were not consistent with the intention‐to‐treat approach, which could have affected the time‐to‐event analysis. Concerns about the results of this trial are echoed in comments from other trial authors in the same field, as referenced in the <a href="./references#CD009012-sec-0128" title="">Characteristics of included studies</a> tables. </p> </section> </section> <section id="CD009012-sec-0080"> <h3 class="title" id="CD009012-sec-0080">Effects of interventions</h3> <p>See: <a href="./full#CD009012-tbl-0001"><b>Summary of findings for the main comparison</b> Early ART compared to delayed ART initiation in HIV‐positive people with cryptococcal meningitis</a> </p> <section id="CD009012-sec-0081"> <h4 class="title">Early (&lt; 4 weeks) versus delayed (≥ 4 weeks) ART initiation in HIV‐positive people with cryptococcal meningitis </h4> <p>Four trials with 294 participants contributed data to this comparison. See also <a href="./full#CD009012-tbl-0001">summary of findings Table for the main comparison</a> for a summary of the overall results. </p> <section id="CD009012-sec-0082"> <h5 class="title">Primary outcomes</h5> <section id="CD009012-sec-0083"> <h6 class="title">All‐cause mortality at six to 12 months</h6> <p>There was higher mortality at this time point for those receiving early ART compared to those for whom ART was delayed (risk ratio (RR) 1.42, 95% confidence interval (CI) 1.02 to 1.97; 294 participants, 4 trials; I<sup>2</sup> = 13%; <a href="./references#CD009012-fig-0009" title="">Analysis 1.1</a>; <a href="#CD009012-fig-0004">Figure 4</a>). The certainty of the evidence contributing to this outcome was low due to concerns regarding risk of bias and qualitative heterogeneity in the included trials and imprecision. We conducted a sensitivity analysis including only trials at an overall low risk of bias (<a href="./references#CD009012-fig-0010" title="">Analysis 1.2</a>). </p> <div class="figure" id="CD009012-fig-0004"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 4</div> </div> <hr class="top"/><img alt="Forest plot of comparison: 1 Early versus delayed ART, outcome: 1.1 All‐cause mortality at 6 to 12 months." data-id="CD009012-fig-0004" src="/cdsr/doi/10.1002/14651858.CD009012.pub3/media/CDSR/CD009012/image_n/nCD009012-AFig-FIG04.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison: 1 Early versus delayed ART, outcome: 1.1 All‐cause mortality at 6 to 12 months. </p> </div> </div> </div> </section> </section> <section id="CD009012-sec-0084"> <h5 class="title">Secondary outcomes</h5> <section id="CD009012-sec-0085"> <h6 class="title">Cryptococcal meningitis relapse</h6> <p>There was a trend towards a reduction in cryptococcal meningitis relapse with early ART compared to delayed ART. However, this effect did not reach statistical significance, as the CI included no effect (RR 0.27, 95% CI 0.07 to 1.04; 205 participants, 2 trials; I<sup>2</sup> = 0%; <a href="./references#CD009012-fig-0011" title="">Analysis 1.3</a>; <a href="#CD009012-fig-0005">Figure 5</a>). The certainty of the evidence contributing to this outcome was low due to imprecision (few clinical events). </p> <div class="figure" id="CD009012-fig-0005"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 5</div> </div> <hr class="top"/><img alt="Forest plot of comparison: 1 Early versus delayed ART, outcome: 1.3 Cryptococcal meningitis relapse." data-id="CD009012-fig-0005" src="/cdsr/doi/10.1002/14651858.CD009012.pub3/media/CDSR/CD009012/image_n/nCD009012-AFig-FIG05.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison: 1 Early versus delayed ART, outcome: 1.3 Cryptococcal meningitis relapse. </p> </div> </div> </div> </section> <section id="CD009012-sec-0086"> <h6 class="title">Cerebrospinal fluid fungal clearance</h6> <p>Due to the variability in methods of reporting CSF fungal clearance, we could not pool the results from the two trials that reported on this outcome. We have presented these results narratively in <a href="#CD009012-tbl-0004">Table 3</a>. Both trials found no difference in the rate of CSF fungal clearance between the two trial arms. </p> <div class="table" id="CD009012-tbl-0004"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 3.</span> <span class="table-title">Cerebrospinal fluid fungal clearance results</span></div> <tbody> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Trial ID</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Number of participants assessed for this outcome</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Trial conclusions </b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p><b>Results</b> </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Early ART</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Delayed ART</b> </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD009012-bbs2-0001" title="BissonGP , MolefiM , BellamyS , ThakurR , SteenhoffA , TamuhlaN , et al. Early versus delayed antiretroviral therapy and cerebrospinal fluid fungal clearance in adults with HIV and cryptococcal meningitis. Clinical Infectious Diseases2013;56(8):1165‐73. [DOI: 10.1093/cid/cit019; CN‐00861211] ">Bisson 2013</a><sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>28</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No difference between groups</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Rate of fungal clearance: ‐0.32 log<sub>10</sub> CFUs/mL/day </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Rate of fungal clearance: ‐0.52 log<sub>10</sub> CFUs/mL/day </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD009012-bbs2-0002" title="BoulwareDR , MeyaDB , MuzooraC , RolfesMA , Huppler HullsiekK , MusubireA , et al. Timing of antiretroviral therapy after diagnosis of cryptococcal meningitis. New England Journal of Medicine2014;370(26):2487‐98. [DOI: 10.1056/NEJMoa1312884; CN‐00994166] ">Boulware 2014</a><sup>2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>166</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No difference between groups</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CSF culture positivity at 14 days of amphotericin B therapy: cumulative incidence of 37% (95% CI 26% to 49%) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CSF culture positivity at 14 days of amphotericin B therapy: cumulative incidence of 39% (95% CI 28% to 50%) </p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>Abbreviations: CFU: colony forming units; CI: confidence interval; CSF: cerebrospinal fluid </p> <p><sup>1</sup>The trial authors reported: "The median numbers of CSF CFU measurements for the control and intervention arms, respectively, were 3 (IQR, 2–4 [range, 1–9]) and 4 (IQR, 2–5 [range, 1–7]) (P = .2, rank‐sum test). The generalized estimating equation regression coefficient for the intervention was 0.20 (95% CI, ‐.85 to 1.25), indicating that intervention subjects had a rate of CSF clearance that tended to be 0.20 log10 CSF CFU/mL/day slower than controls, although this difference was not significant."<br/> <sup>2</sup>The trial authors reported: "Similar rates of CSF culture positivity at 14 days (37% in the earlier‐ART group and 39% in the deferred‐ART group, P = 0.87). Among 59 participants with positive CSF cultures at 14 days, the median cryptococcal growth was 100 CFU per millilitre (interquartile range, 15 to 500), with no significant difference between treatment groups (P = 0.13); only 5 participants had more than 10,000 CFU per millilitre in CSF." </p> </div> </div> </section> <section id="CD009012-sec-0087"> <h6 class="title">Mortality hazard ratio</h6> <p>Due to considerable unexplained heterogeneity in the pooled effect estimate from the trials where hazard ratios were provided (237 participants, 3 trials; I<sup>2</sup> = 84%; <a href="./references#CD009012-fig-0012" title="">Analysis 1.4</a>), we did not meta‐analyse this outcome. </p> </section> <section id="CD009012-sec-0088"> <h6 class="title">Cryptococcal IRIS</h6> <p>There was a suggestion of an increased risk of cryptococcal IRIS associated with early ART (RR 3.56, 95% CI 0.51 to 25.02; 205 participants, 2 trials; I<sup>2</sup> = 54%; <a href="./references#CD009012-fig-0013" title="">Analysis 1.5</a>; <a href="#CD009012-fig-0006">Figure 6</a>). However, the CI around this estimate was very wide and included no effect. The certainty of the evidence for this outcome was very low due to marked imprecision of the estimate, risk of bias, and indirectness related to the IRIS assessment. We explored the use of available‐case analysis for this outcome in a sensitivity analysis (<a href="./references#CD009012-fig-0014" title="">Analysis 1.6</a>, <a href="#CD009012-fig-0007">Figure 7</a>). </p> <div class="figure" id="CD009012-fig-0006"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 6</div> </div> <hr class="top"/><img alt="Forest plot of comparison: 1 Early versus delayed ART, outcome: 1.5 Cryptococcal IRIS." data-id="CD009012-fig-0006" src="/cdsr/doi/10.1002/14651858.CD009012.pub3/media/CDSR/CD009012/image_n/nCD009012-AFig-FIG06.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison: 1 Early versus delayed ART, outcome: 1.5 Cryptococcal IRIS.</p> </div> </div> </div> <div class="figure" id="CD009012-fig-0007"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 7</div> </div> <hr class="top"/><img alt="Forest plot of comparison: 1 Early versus delayed ART, outcome: 1.6 Sensitivity analysis: cryptococcal IRIS." data-id="CD009012-fig-0007" src="/cdsr/doi/10.1002/14651858.CD009012.pub3/media/CDSR/CD009012/image_n/nCD009012-AFig-FIG07.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison: 1 Early versus delayed ART, outcome: 1.6 Sensitivity analysis: cryptococcal IRIS. </p> </div> </div> </div> </section> <section id="CD009012-sec-0089"> <h6 class="title">HIV virological suppression</h6> <p>There was little to no difference in virological suppression at 24 weeks with early ART compared to delayed ART (RR 0.93, 95% CI 0.72 to 1.22; 205 participants, 2 trials; I<sup>2</sup> = 0%; <a href="./references#CD009012-fig-0015" title="">Analysis 1.7</a>). The certainty of the evidence contributing to this outcome was very low due to high risk of bias and imprecision (few clinical events). We explored the use of available‐case analysis for this outcome in a sensitivity analysis (<a href="./references#CD009012-fig-0016" title="">Analysis 1.8</a>; <a href="#CD009012-fig-0008">Figure 8</a>). </p> <div class="figure" id="CD009012-fig-0008"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 8</div> </div> <hr class="top"/><img alt="Forest plot of comparison: 1 Early versus delayed ART, outcome: 1.8 Sensitivity analysis: virological suppression at 24 weeks." data-id="CD009012-fig-0008" src="/cdsr/doi/10.1002/14651858.CD009012.pub3/media/CDSR/CD009012/image_n/nCD009012-AFig-FIG08.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison: 1 Early versus delayed ART, outcome: 1.8 Sensitivity analysis: virological suppression at 24 weeks. </p> </div> </div> </div> </section> <section id="CD009012-sec-0090"> <h6 class="title">Length of hospital stay</h6> <p>No trials reported length of hospital stay as an outcome. <a href="./references#CD009012-bbs2-0001" title="BissonGP , MolefiM , BellamyS , ThakurR , SteenhoffA , TamuhlaN , et al. Early versus delayed antiretroviral therapy and cerebrospinal fluid fungal clearance in adults with HIV and cryptococcal meningitis. Clinical Infectious Diseases2013;56(8):1165‐73. [DOI: 10.1093/cid/cit019; CN‐00861211] ">Bisson 2013</a> reported only prolonged hospitalizations as 2 (15%) and 4 (29%) in early and delayed ART arms, respectively. </p> </section> <section id="CD009012-sec-0091"> <h6 class="title">Adverse events</h6> <p>Adverse event measures were not reported consistently between trials, therefore these data could not be meta‐analysed. <a href="./references#CD009012-bbs2-0001" title="BissonGP , MolefiM , BellamyS , ThakurR , SteenhoffA , TamuhlaN , et al. Early versus delayed antiretroviral therapy and cerebrospinal fluid fungal clearance in adults with HIV and cryptococcal meningitis. Clinical Infectious Diseases2013;56(8):1165‐73. [DOI: 10.1093/cid/cit019; CN‐00861211] ">Bisson 2013</a> reported that all 14 participants in the early ART arm and 13/14 participants in the delayed ART arm experienced at least one grade 3 to 5 adverse event. <a href="./references#CD009012-bbs2-0002" title="BoulwareDR , MeyaDB , MuzooraC , RolfesMA , Huppler HullsiekK , MusubireA , et al. Timing of antiretroviral therapy after diagnosis of cryptococcal meningitis. New England Journal of Medicine2014;370(26):2487‐98. [DOI: 10.1056/NEJMoa1312884; CN‐00994166] ">Boulware 2014</a> reported the cumulative incidence of grade 3 to 5 adverse events as 84% (95% CI 74% to 90%) in the early ART group and 84% (95% CI 75% to 91%) in the delayed ART group. <a href="./references#CD009012-bbs2-0003" title="MakadzangeAT , NdhlovuCE , TakarindaK , ReidM , KurangwaM , GonaP , et al. Early versus delayed initiation of antiretroviral therapy for concurrent HIV infection and cryptococcal meningitis in sub‐Saharan Africa. Clinical Infectious Diseases2010;50(11):1532‐8. [DOI: 10.1086/652652; CN‐00748368] ">Makadzange 2010</a> described one episode of desquamating skin rash related to nevirapine and that liver function tests remained normal throughout the trial. <a href="./references#CD009012-bbs2-0004" title="ZolopaA , AndersenJ , PowderlyW , SanchezA , SanneI , SuckowC , et al. Early antiretroviral therapy reduces AIDS progression/death in individuals with acute opportunistic infections: a multicenter randomized strategy trial. PLoS ONE2009;4(5):e5575. [DOI: 10.1371/journal.pone.0005575; CN‐00702077] ">Zolopa 2009</a> did not report adverse events specifically for participants with cryptococcal meningitis. </p> </section> </section> <section id="CD009012-sec-0092"> <h5 class="title">Subgroup analyses</h5> <section id="CD009012-sec-0093"> <h6 class="title">All‐cause mortality by antifungal therapy</h6> <p>We subgrouped the primary outcome of all‐cause mortality according to type of antifungal therapy used. Among trials where amphotericin B therapy was combined with fluconazole (<a href="./references#CD009012-bbs2-0001" title="BissonGP , MolefiM , BellamyS , ThakurR , SteenhoffA , TamuhlaN , et al. Early versus delayed antiretroviral therapy and cerebrospinal fluid fungal clearance in adults with HIV and cryptococcal meningitis. Clinical Infectious Diseases2013;56(8):1165‐73. [DOI: 10.1093/cid/cit019; CN‐00861211] ">Bisson 2013</a>; <a href="./references#CD009012-bbs2-0002" title="BoulwareDR , MeyaDB , MuzooraC , RolfesMA , Huppler HullsiekK , MusubireA , et al. Timing of antiretroviral therapy after diagnosis of cryptococcal meningitis. New England Journal of Medicine2014;370(26):2487‐98. [DOI: 10.1056/NEJMoa1312884; CN‐00994166] ">Boulware 2014</a>), there was substantial unexplained heterogeneity between trials (I<sup>2</sup> = 66%), and effect estimates were not pooled. A further trial treated cryptococcal meningitis with fluconazole monotherapy (<a href="./references#CD009012-bbs2-0003" title="MakadzangeAT , NdhlovuCE , TakarindaK , ReidM , KurangwaM , GonaP , et al. Early versus delayed initiation of antiretroviral therapy for concurrent HIV infection and cryptococcal meningitis in sub‐Saharan Africa. Clinical Infectious Diseases2010;50(11):1532‐8. [DOI: 10.1086/652652; CN‐00748368] ">Makadzange 2010</a>); the results of this trial indicated that those who initiated ART early had higher mortality compared to those who initiated ART later (RR 1.57, 95% CI 1.02 to 2.42; 54 participants; <a href="./references#CD009012-fig-0017" title="">Analysis 1.9</a>). <a href="./references#CD009012-bbs2-0004" title="ZolopaA , AndersenJ , PowderlyW , SanchezA , SanneI , SuckowC , et al. Early antiretroviral therapy reduces AIDS progression/death in individuals with acute opportunistic infections: a multicenter randomized strategy trial. PLoS ONE2009;4(5):e5575. [DOI: 10.1371/journal.pone.0005575; CN‐00702077] ">Zolopa 2009</a> did not specify which antifungal therapy was used (RR 0.85, 95% CI 0.08 to 8.44; 35 participants; <a href="./references#CD009012-fig-0017" title="">Analysis 1.9</a>) and showed no overall difference in mortality between the treatment arms. </p> </section> </section> <section id="CD009012-sec-0094"> <h5 class="title">Sensitivity analyses</h5> <section id="CD009012-sec-0095"> <h6 class="title">All‐cause mortality</h6> <p>We explored the effect of the intervention on all‐cause mortality at six months by restricting the analysis to trials with low risk of bias for sequence generation, attrition, and other bias that could influence this outcome. </p> <p>Only the Cryptococcal Optimal ART Timing (COAT) trial, <a href="./references#CD009012-bbs2-0002" title="BoulwareDR , MeyaDB , MuzooraC , RolfesMA , Huppler HullsiekK , MusubireA , et al. Timing of antiretroviral therapy after diagnosis of cryptococcal meningitis. New England Journal of Medicine2014;370(26):2487‐98. [DOI: 10.1056/NEJMoa1312884; CN‐00994166] ">Boulware 2014</a>, contributed to this analysis. The results from this trial indicated a higher risk of mortality among those who initiated ART early compared to those who delayed ART (RR 1.50, 95% CI 1.02 to 2.21; 177 participants, 1 trial; <a href="./references#CD009012-fig-0010" title="">Analysis 1.2</a>). </p> </section> <section id="CD009012-sec-0096"> <h6 class="title">Cryptococcal IRIS</h6> <p>Applying an available‐case analysis (RR 2.97, 95% CI 0.38 to 23.25; <a href="./references#CD009012-fig-0014" title="">Analysis 1.6</a>: <a href="#CD009012-fig-0007">Figure 7</a>) and applying a low (8%) or high (46%) occurrence of cryptococcal IRIS to the missing cases differentially in the best‐case (RR 1.56, 95% CI 0.45 to 5.40) and worst‐case scenarios (RR 3.73, 95% CI 0.37 to 38.07) only resulted in a lower or higher precision estimate. In all instances, the estimates included no effect, and CIs remained wide and included appreciable benefit and harm. These results are in keeping with the intention‐to treat analysis suggesting that this approach was reasonable for the analysis of cryptococcal IRIS. </p> </section> <section id="CD009012-sec-0097"> <h6 class="title">Virological suppression on ART</h6> <p>We compared the use of an available‐case analysis and best‐ and worst‐case scenarios to evaluate missing data for this outcome. This resulted in a persistent result of no difference in virological suppression at six months between groups in the available‐case analysis (RR 1.10, 95% CI 0.96 to 1.27; <a href="./references#CD009012-fig-0016" title="">Analysis 1.8</a>; <a href="#CD009012-fig-0008">Figure 8</a>). For the best‐case scenario, we assumed 89% virological suppression for those missing viral loads or who did not receive ART in the early ART group and 50% for those missing in the delayed ART group. This resulted in better virological suppression in the early ART group (RR 1.26, 95% CI 1.10 to 1.45). When we applied the worst‐case scenario and assumed that those missing viral loads or who did not receive ART in the early ART group had 50% suppression and in the delayed ART group had 89% suppression, this resulted in better virological suppression in the delayed ART group (RR 0.84, 95% CI 0.72 to 0.96). This suggested that the missing data for virological outcomes could bias results for this outcome and led to a downgrading of this outcome in the GRADE assessment. </p> </section> </section> <section id="CD009012-sec-0098"> <h5 class="title">Certainty of the evidence</h5> <p>We used GRADE to indicate the level of confidence we have in the results. The certainty of the evidence was either low or very low for most outcomes. </p> <section id="CD009012-sec-0099"> <h6 class="title">Methodological quality</h6> <p>The overall methodological quality was unclear for most trials that contributed to the analyses, due predominantly to the lack of reporting on several 'Risk of bias' domains. We categorized <a href="./references#CD009012-bbs2-0003" title="MakadzangeAT , NdhlovuCE , TakarindaK , ReidM , KurangwaM , GonaP , et al. Early versus delayed initiation of antiretroviral therapy for concurrent HIV infection and cryptococcal meningitis in sub‐Saharan Africa. Clinical Infectious Diseases2010;50(11):1532‐8. [DOI: 10.1086/652652; CN‐00748368] ">Makadzange 2010</a> as at high risk of bias for three domains, and the inclusion of this trial in the mortality analyses resulted in downgrading for risk of bias for these outcomes. Due to the lack of blinding of IRIS outcome assessors in one trial, we downgraded the evidence that contributed to the IRIS analysis. Viral load analysis was not conducted for all participants who were randomized or who received ART; we downgraded the certainty of the evidence for this outcome, as it is possible that randomization was not maintained for the subgroup that was analysed for this outcome. </p> </section> <section id="CD009012-sec-0100"> <h6 class="title">Consistency</h6> <p>We detected qualitative and quantitative heterogeneity in the analysis of mortality, which led to downgrading the certainty of the evidence for the all‐cause mortality outcome and prevented pooling of the results of the mortality hazard ratio outcome. We explored the use of different antifungal regimens in a subgroup analysis and found substantial heterogeneity between the trials providing amphotericin B, reflecting differences between these trials that could not be explained. This inconsistency could be the result of differences in the trial setting and conduct, however it was not possible to fully account for this in subgroup analyses. </p> </section> <section id="CD009012-sec-0101"> <h6 class="title">Indirectness</h6> <p>We downgraded the cryptococcal IRIS outcome for indirectness, as we considered IRIS assessment to be quite subjective even when case definitions are applied. </p> </section> <section id="CD009012-sec-0102"> <h6 class="title">Imprecision</h6> <p>We downgraded all outcomes due to imprecision. There were overall few clinical events contributing to each analysis. In addition, several analyses had wide CIs including no effect and appreciable harm or benefit. </p> </section> <section id="CD009012-sec-0103"> <h6 class="title">Publication bias and other considerations</h6> <p>It was not possible to formally assess publication bias using funnel plots. However, there was no evidence of publication bias among the included trials, which presented both results with no effect or moderate effects of early ART on mortality. </p> </section> </section> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD009012-sec-0104" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD009012-sec-0104"></div> <section id="CD009012-sec-0105"> <h3 class="title" id="CD009012-sec-0105">Summary of main results</h3> <p>Four trials including a total of 294 participants evaluated early ART initiation compared to delayed ART initiation (<a href="./full#CD009012-tbl-0001">summary of findings Table for the main comparison</a>). The trials were conducted between 2003 and 2011, and all included people from low‐ and middle‐income countries. Two trials used amphotericin B and fluconazole for cryptococcal meningitis induction therapy; one trial used fluconazole monotherapy; and one trial did not report the induction therapy used. All trials were conducted in adults. </p> <section id="CD009012-sec-0106"> <h4 class="title">Primary outcomes</h4> <p>Overall, when we pooled results from the four included trials we found that early ART initiation may increase all‐cause mortality at six to 12 months among HIV‐positive adults with cryptococcal meningitis, with low‐certainty evidence contributing to this meta‐analysis. A sensitivity analysis restricted to trials at low risk of bias showed higher risk of mortality among those initiating ART early; this analysis included one high‐quality trial (COAT trial), which was terminated early due to the higher mortality risk in the early ART group. </p> </section> <section id="CD009012-sec-0107"> <h4 class="title">Secondary outcomes</h4> <p>There was low‐certainty evidence suggesting that early ART initiation may reduce the occurrence of cryptococcal meningitis relapse. Two RCTs evaluating the risk of developing IRIS found a tendency towards increased risk of cryptococcal IRIS in the early ART group, however the very low‐certainty evidence contributing to this outcome means that we cannot say whether early ART initiation increases or decreases cryptococcal IRIS events compared to delayed ART initiation. We are uncertain if early ART affects virological suppression at six months, as the evidence contributing to this outcome was of very low certainty. Adverse events were not reported consistently between trials, therefore could not meta‐analyse this outcome. Conclusions from the authors of trials that assessed this outcome suggest no difference in grade 3 to 5 adverse events between the two treatment arms. Similarly, data from the two trials reporting on time to fungal clearance could not be pooled, and the authors of these trials concluded that there was no difference between early and delayed ART arms for this outcome. </p> </section> </section> <section id="CD009012-sec-0108"> <h3 class="title" id="CD009012-sec-0108">Overall completeness and applicability of evidence</h3> <p>We found only a few small trials that evaluated early versus delayed ART initiation in HIV‐positive people with cryptococcal meningitis. The trials were generally conducted in low‐ and middle‐income countries and included only adult participants. The results from this review can therefore be generalized only to these groups. The overall low certainty of the evidence limits the conclusions that can be drawn from these analyses. However, the pooled results do suggest that early ART may increase all‐cause mortality. We were restricted in the number of subgroup and sensitivity analyses that we could perform due to the limited number of included trials and participants. When we restricted analyses to trials at low risk of bias for the primary outcome, the analysis contained one trial (<a href="./references#CD009012-bbs2-0002" title="BoulwareDR , MeyaDB , MuzooraC , RolfesMA , Huppler HullsiekK , MusubireA , et al. Timing of antiretroviral therapy after diagnosis of cryptococcal meningitis. New England Journal of Medicine2014;370(26):2487‐98. [DOI: 10.1056/NEJMoa1312884; CN‐00994166] ">Boulware 2014</a>); these results showed a higher risk of mortality among those who initiated ART early. In addition, two of the included studies with the highest numbers of participants and showing higher mortality with early ART were terminated early due to excessive mortality in the early ART group. One needs to consider whether effect estimates would be higher if these trials had larger samples. </p> <p>Only two trials reported using amphotericin B‐based induction therapy, which is the standard of care for treatment of people with cryptococcal meningitis. Although fluconazole monotherapy is not routinely recommended, in many low‐ and middle‐income countries this single agent may still be used, and so findings from this trial remain relevant to these settings. </p> <p>Immune reconstitution inflammatory syndrome has been implicated as the reason for higher mortality in those who initiate ART early. Unfortunately, we could draw no conclusions on the effect of early ART on IRIS occurrence based on the available data. </p> <section id="CD009012-sec-0109"> <h4 class="title">Certainty of the evidence</h4> <p>Overall, the certainty of the evidence contributing to all outcomes was low or very low. This was due to generally few clinical events and wide CIs around effect estimates. In addition, the poor methodological quality of some trials that contributed to the mortality, cryptococcal meningitis IRIS, and virological suppression analyses led to further downgrading of these outcomes. </p> </section> </section> <section id="CD009012-sec-0110"> <h3 class="title" id="CD009012-sec-0110">Potential biases in the review process</h3> <p>We minimized selection bias by conducting an extensive literature search using a wide range of search terms and databases. Two review authors independently screened the search outputs and evaluated eligibility. In addition, we evaluated the reference lists of included papers and previous systematic reviews. </p> <p>We have detailed any changes made to the trial protocol after publication and after the review process began in the <a href="#CD009012-sec-0126">Differences between protocol and review</a> section. </p> </section> <section id="CD009012-sec-0111"> <h3 class="title" id="CD009012-sec-0111">Agreements and disagreements with other studies or reviews</h3> <p>A previous Cochrane Review conducted by <a href="./references#CD009012-bbs2-0045" title="NjeiB , KongnyuyEJ , KumarS , OkwenMP , SankarMJ , MbuagbawL . Optimal timing for antiretroviral therapy initiation in patients with HIV infection and concurrent cryptococcal meningitis. Cochrane Database of Systematic Reviews2013, Issue 2. [DOI: 10.1002/14651858.CD009012.pub2] ">Njei 2013</a> included two of the four trials included in this review (<a href="./references#CD009012-bbs2-0003" title="MakadzangeAT , NdhlovuCE , TakarindaK , ReidM , KurangwaM , GonaP , et al. Early versus delayed initiation of antiretroviral therapy for concurrent HIV infection and cryptococcal meningitis in sub‐Saharan Africa. Clinical Infectious Diseases2010;50(11):1532‐8. [DOI: 10.1086/652652; CN‐00748368] ">Makadzange 2010</a>; <a href="./references#CD009012-bbs2-0004" title="ZolopaA , AndersenJ , PowderlyW , SanchezA , SanneI , SuckowC , et al. Early antiretroviral therapy reduces AIDS progression/death in individuals with acute opportunistic infections: a multicenter randomized strategy trial. PLoS ONE2009;4(5):e5575. [DOI: 10.1371/journal.pone.0005575; CN‐00702077] ">Zolopa 2009</a>). They concluded that there was insufficient evidence to determine whether early ART had an effect on mortality and suggested that there was a higher risk of IRIS among those who initiated ART early. Although our review did show some evidence of higher risk of IRIS in the early ART group, the certainty of the evidence contributing to this outcome was very low. The additional trials that contributed to this updated review, and rigorous application of the GRADE tool, resulted in low‐certainty evidence of higher mortality among those who initiated ART early. </p> <p>These findings contrast with cohort studies, which suggest no difference in mortality risk when comparing early ART to delayed ART (<a href="#CD009012-tbl-0002">Table 1</a>). This may reflect some level of selection bias for this outcome in cohort studies. </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD009012-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009012.pub3/media/CDSR/CD009012/urn:x-wiley:14651858:media:CD009012:CD009012-AFig-FIG01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009012.pub3/media/CDSR/CD009012/image_t/tCD009012-AFig-FIG01.png" target="_blank"><b></b></a></p> </div><img alt="Study flow diagram." data-id="CD009012-fig-0001" src="/cdsr/doi/10.1002/14651858.CD009012.pub3/media/CDSR/CD009012/image_n/nCD009012-AFig-FIG01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p> Study flow diagram.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009012.pub3/full#CD009012-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009012.pub3/media/CDSR/CD009012/image_n/nCD009012-AFig-FIG01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009012-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009012.pub3/media/CDSR/CD009012/urn:x-wiley:14651858:media:CD009012:CD009012-AFig-FIG02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009012.pub3/media/CDSR/CD009012/image_t/tCD009012-AFig-FIG02.png" target="_blank"><b></b></a></p> </div><img alt="‘Risk of bias' summary: review authors' judgements about each ‘Risk of bias' item for each included trial." data-id="CD009012-fig-0002" src="/cdsr/doi/10.1002/14651858.CD009012.pub3/media/CDSR/CD009012/image_n/nCD009012-AFig-FIG02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>‘Risk of bias' summary: review authors' judgements about each ‘Risk of bias' item for each included trial. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009012.pub3/full#CD009012-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009012.pub3/media/CDSR/CD009012/image_n/nCD009012-AFig-FIG02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009012-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009012.pub3/media/CDSR/CD009012/urn:x-wiley:14651858:media:CD009012:CD009012-AFig-FIG03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009012.pub3/media/CDSR/CD009012/image_t/tCD009012-AFig-FIG03.png" target="_blank"><b></b></a></p> </div><img alt="‘Risk of bias' graph: review authors' judgements about each ‘Risk of bias' item presented as percentages across all included trials." data-id="CD009012-fig-0003" src="/cdsr/doi/10.1002/14651858.CD009012.pub3/media/CDSR/CD009012/image_n/nCD009012-AFig-FIG03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>‘Risk of bias' graph: review authors' judgements about each ‘Risk of bias' item presented as percentages across all included trials. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009012.pub3/full#CD009012-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009012.pub3/media/CDSR/CD009012/image_n/nCD009012-AFig-FIG03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009012-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009012.pub3/media/CDSR/CD009012/urn:x-wiley:14651858:media:CD009012:CD009012-AFig-FIG04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009012.pub3/media/CDSR/CD009012/image_t/tCD009012-AFig-FIG04.png" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison: 1 Early versus delayed ART, outcome: 1.1 All‐cause mortality at 6 to 12 months." data-id="CD009012-fig-0004" src="/cdsr/doi/10.1002/14651858.CD009012.pub3/media/CDSR/CD009012/image_n/nCD009012-AFig-FIG04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 4</div> <div class="figure-caption"> <p>Forest plot of comparison: 1 Early versus delayed ART, outcome: 1.1 All‐cause mortality at 6 to 12 months. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009012.pub3/full#CD009012-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009012.pub3/media/CDSR/CD009012/image_n/nCD009012-AFig-FIG04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009012-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009012.pub3/media/CDSR/CD009012/urn:x-wiley:14651858:media:CD009012:CD009012-AFig-FIG05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009012.pub3/media/CDSR/CD009012/image_t/tCD009012-AFig-FIG05.png" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison: 1 Early versus delayed ART, outcome: 1.3 Cryptococcal meningitis relapse." data-id="CD009012-fig-0005" src="/cdsr/doi/10.1002/14651858.CD009012.pub3/media/CDSR/CD009012/image_n/nCD009012-AFig-FIG05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 5</div> <div class="figure-caption"> <p>Forest plot of comparison: 1 Early versus delayed ART, outcome: 1.3 Cryptococcal meningitis relapse. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009012.pub3/full#CD009012-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009012.pub3/media/CDSR/CD009012/image_n/nCD009012-AFig-FIG05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009012-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009012.pub3/media/CDSR/CD009012/urn:x-wiley:14651858:media:CD009012:CD009012-AFig-FIG06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009012.pub3/media/CDSR/CD009012/image_t/tCD009012-AFig-FIG06.png" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison: 1 Early versus delayed ART, outcome: 1.5 Cryptococcal IRIS." data-id="CD009012-fig-0006" src="/cdsr/doi/10.1002/14651858.CD009012.pub3/media/CDSR/CD009012/image_n/nCD009012-AFig-FIG06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 6</div> <div class="figure-caption"> <p>Forest plot of comparison: 1 Early versus delayed ART, outcome: 1.5 Cryptococcal IRIS.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009012.pub3/full#CD009012-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009012.pub3/media/CDSR/CD009012/image_n/nCD009012-AFig-FIG06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009012-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009012.pub3/media/CDSR/CD009012/urn:x-wiley:14651858:media:CD009012:CD009012-AFig-FIG07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009012.pub3/media/CDSR/CD009012/image_t/tCD009012-AFig-FIG07.png" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison: 1 Early versus delayed ART, outcome: 1.6 Sensitivity analysis: cryptococcal IRIS." data-id="CD009012-fig-0007" src="/cdsr/doi/10.1002/14651858.CD009012.pub3/media/CDSR/CD009012/image_n/nCD009012-AFig-FIG07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 7</div> <div class="figure-caption"> <p>Forest plot of comparison: 1 Early versus delayed ART, outcome: 1.6 Sensitivity analysis: cryptococcal IRIS. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009012.pub3/full#CD009012-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009012.pub3/media/CDSR/CD009012/image_n/nCD009012-AFig-FIG07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009012-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009012.pub3/media/CDSR/CD009012/urn:x-wiley:14651858:media:CD009012:CD009012-AFig-FIG08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009012.pub3/media/CDSR/CD009012/image_t/tCD009012-AFig-FIG08.png" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison: 1 Early versus delayed ART, outcome: 1.8 Sensitivity analysis: virological suppression at 24 weeks." data-id="CD009012-fig-0008" src="/cdsr/doi/10.1002/14651858.CD009012.pub3/media/CDSR/CD009012/image_n/nCD009012-AFig-FIG08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 8</div> <div class="figure-caption"> <p>Forest plot of comparison: 1 Early versus delayed ART, outcome: 1.8 Sensitivity analysis: virological suppression at 24 weeks. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009012.pub3/full#CD009012-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009012.pub3/media/CDSR/CD009012/image_n/nCD009012-AFig-FIG08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009012-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009012.pub3/media/CDSR/CD009012/urn:x-wiley:14651858:media:CD009012:CD009012-CMP-001-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009012.pub3/media/CDSR/CD009012/image_t/tCD009012-CMP-001-01.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Early versus delayed ART, Outcome 1 All‐cause mortality at 6 to 12 months." data-id="CD009012-fig-0009" src="/cdsr/doi/10.1002/14651858.CD009012.pub3/media/CDSR/CD009012/image_n/nCD009012-CMP-001-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1 Early versus delayed ART, Outcome 1 All‐cause mortality at 6 to 12 months.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009012.pub3/references#CD009012-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009012.pub3/media/CDSR/CD009012/image_n/nCD009012-CMP-001-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009012-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009012.pub3/media/CDSR/CD009012/urn:x-wiley:14651858:media:CD009012:CD009012-CMP-001-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009012.pub3/media/CDSR/CD009012/image_t/tCD009012-CMP-001-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Early versus delayed ART, Outcome 2 Sensitivity analysis: all‐cause mortality." data-id="CD009012-fig-0010" src="/cdsr/doi/10.1002/14651858.CD009012.pub3/media/CDSR/CD009012/image_n/nCD009012-CMP-001-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1 Early versus delayed ART, Outcome 2 Sensitivity analysis: all‐cause mortality.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009012.pub3/references#CD009012-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009012.pub3/media/CDSR/CD009012/image_n/nCD009012-CMP-001-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009012-fig-0011"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009012.pub3/media/CDSR/CD009012/urn:x-wiley:14651858:media:CD009012:CD009012-CMP-001-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009012.pub3/media/CDSR/CD009012/image_t/tCD009012-CMP-001-03.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Early versus delayed ART, Outcome 3 Cryptococcal meningitis relapse." data-id="CD009012-fig-0011" src="/cdsr/doi/10.1002/14651858.CD009012.pub3/media/CDSR/CD009012/image_n/nCD009012-CMP-001-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1 Early versus delayed ART, Outcome 3 Cryptococcal meningitis relapse.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009012.pub3/references#CD009012-fig-0011">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009012.pub3/media/CDSR/CD009012/image_n/nCD009012-CMP-001-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009012-fig-0012"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009012.pub3/media/CDSR/CD009012/urn:x-wiley:14651858:media:CD009012:CD009012-CMP-001-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009012.pub3/media/CDSR/CD009012/image_t/tCD009012-CMP-001-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Early versus delayed ART, Outcome 4 Mortality hazard ratio." data-id="CD009012-fig-0012" src="/cdsr/doi/10.1002/14651858.CD009012.pub3/media/CDSR/CD009012/image_n/nCD009012-CMP-001-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.4</div> <div class="figure-caption"> <p>Comparison 1 Early versus delayed ART, Outcome 4 Mortality hazard ratio.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009012.pub3/references#CD009012-fig-0012">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009012.pub3/media/CDSR/CD009012/image_n/nCD009012-CMP-001-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009012-fig-0013"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009012.pub3/media/CDSR/CD009012/urn:x-wiley:14651858:media:CD009012:CD009012-CMP-001-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009012.pub3/media/CDSR/CD009012/image_t/tCD009012-CMP-001-05.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Early versus delayed ART, Outcome 5 Cryptococcal IRIS." data-id="CD009012-fig-0013" src="/cdsr/doi/10.1002/14651858.CD009012.pub3/media/CDSR/CD009012/image_n/nCD009012-CMP-001-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.5</div> <div class="figure-caption"> <p>Comparison 1 Early versus delayed ART, Outcome 5 Cryptococcal IRIS.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009012.pub3/references#CD009012-fig-0013">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009012.pub3/media/CDSR/CD009012/image_n/nCD009012-CMP-001-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009012-fig-0014"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009012.pub3/media/CDSR/CD009012/urn:x-wiley:14651858:media:CD009012:CD009012-CMP-001-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009012.pub3/media/CDSR/CD009012/image_t/tCD009012-CMP-001-06.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Early versus delayed ART, Outcome 6 Sensitivity analysis: cryptococcal IRIS." data-id="CD009012-fig-0014" src="/cdsr/doi/10.1002/14651858.CD009012.pub3/media/CDSR/CD009012/image_n/nCD009012-CMP-001-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.6</div> <div class="figure-caption"> <p>Comparison 1 Early versus delayed ART, Outcome 6 Sensitivity analysis: cryptococcal IRIS. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009012.pub3/references#CD009012-fig-0014">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009012.pub3/media/CDSR/CD009012/image_n/nCD009012-CMP-001-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009012-fig-0015"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009012.pub3/media/CDSR/CD009012/urn:x-wiley:14651858:media:CD009012:CD009012-CMP-001-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009012.pub3/media/CDSR/CD009012/image_t/tCD009012-CMP-001-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Early versus delayed ART, Outcome 7 Virological suppression at 24 weeks (viral load &lt; 400 copies/mL)." data-id="CD009012-fig-0015" src="/cdsr/doi/10.1002/14651858.CD009012.pub3/media/CDSR/CD009012/image_n/nCD009012-CMP-001-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.7</div> <div class="figure-caption"> <p>Comparison 1 Early versus delayed ART, Outcome 7 Virological suppression at 24 weeks (viral load &lt; 400 copies/mL). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009012.pub3/references#CD009012-fig-0015">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009012.pub3/media/CDSR/CD009012/image_n/nCD009012-CMP-001-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009012-fig-0016"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009012.pub3/media/CDSR/CD009012/urn:x-wiley:14651858:media:CD009012:CD009012-CMP-001-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009012.pub3/media/CDSR/CD009012/image_t/tCD009012-CMP-001-08.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Early versus delayed ART, Outcome 8 Sensitivity analysis: virological suppression at 24 weeks." data-id="CD009012-fig-0016" src="/cdsr/doi/10.1002/14651858.CD009012.pub3/media/CDSR/CD009012/image_n/nCD009012-CMP-001-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.8</div> <div class="figure-caption"> <p>Comparison 1 Early versus delayed ART, Outcome 8 Sensitivity analysis: virological suppression at 24 weeks. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009012.pub3/references#CD009012-fig-0016">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009012.pub3/media/CDSR/CD009012/image_n/nCD009012-CMP-001-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009012-fig-0017"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009012.pub3/media/CDSR/CD009012/urn:x-wiley:14651858:media:CD009012:CD009012-CMP-001-09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009012.pub3/media/CDSR/CD009012/image_t/tCD009012-CMP-001-09.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Early versus delayed ART, Outcome 9 Subgrouping by antifungal drug: all‐cause mortality." data-id="CD009012-fig-0017" src="/cdsr/doi/10.1002/14651858.CD009012.pub3/media/CDSR/CD009012/image_n/nCD009012-CMP-001-09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.9</div> <div class="figure-caption"> <p>Comparison 1 Early versus delayed ART, Outcome 9 Subgrouping by antifungal drug: all‐cause mortality. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009012.pub3/references#CD009012-fig-0017">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009012.pub3/media/CDSR/CD009012/image_n/nCD009012-CMP-001-09.png" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD009012-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Early ART compared to delayed ART initiation in HIV‐positive people with cryptococcal meningitis</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Early ART compared to delayed ART initiation in HIV‐positive people with cryptococcal meningitis</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> HIV‐positive people with cryptococcal meningitis<br/> <b>Setting:</b> global<br/> <b>Intervention:</b> early ART initiation (less than 4 weeks after initiation of cryptococcal meningitis treatment)<br/> <b>Comparison:</b> delayed ART initiation (more than 4 weeks after initiation of cryptococcal meningitis treatment) </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="center" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Number of participants<br/> (trials)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with delayed ART</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with early ART</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>All‐cause mortality at 6 to 12 months</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>311 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>442 per 1000<br/> (317 to 613) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 1.42<br/> (1.02 to 1.97) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>294<br/> (4 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> LOW<sup>1,2,3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Early ART initiation may increase the risk of mortality at 6 to 12 months.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cryptococcal meningitis relapse</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>87 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>24 per 1000<br/> (6 to 91) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 0.27<br/> (0.07 to 1.04) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>205<br/> (2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> LOW<sup>4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Early ART initiation may reduce relapses of cryptococcal meningitis compared to delayed ART initiation. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cryptococcal IRIS</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>87 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>311 per 1000<br/> (45 to 1000) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 3.56<br/> (0.51 to 25.02) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>205<br/> (2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW<sup>4,5,6</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>We are uncertain as to whether or not early ART initiation increases or reduces cryptococcal IRIS events compared to delayed ART initiation. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>HIV virological suppression at 6 months (viral load &lt; 400 copies/mL)</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>534 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>497 per 1000<br/> (384 to 651) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 0.93 (0.72 to 1.22)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>205<br/> (2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW<sup>7,8</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>We are uncertain as to whether or not early ART initiation increases or reduces virological suppression at 6 months compared to delayed ART initiation. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% CI) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). </p> <p><b>Abbreviations: ART:</b> antiretroviral therapy; <b>CI:</b> confidence interval; <b>IRIS:</b> immune reconstitution inflammatory syndrome; <b>RCT:</b> randomized controlled trial; <b>RR:</b> risk ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/> <b>Moderate certainty:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/> <b>Low certainty:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/> <b>Very low certainty:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>Risk of bias: downgraded by a half point due to high risk of other bias in <a href="./references#CD009012-bbs2-0003" title="MakadzangeAT , NdhlovuCE , TakarindaK , ReidM , KurangwaM , GonaP , et al. Early versus delayed initiation of antiretroviral therapy for concurrent HIV infection and cryptococcal meningitis in sub‐Saharan Africa. Clinical Infectious Diseases2010;50(11):1532‐8. [DOI: 10.1086/652652; CN‐00748368] ">Makadzange 2010</a>.<br/> <sup>2</sup>Imprecision: downgraded by 1 for wide CIs including no effect and appreciable harm. In addition, there were few clinical events (&lt; 200).<br/> <sup>3</sup>Heterogeneity: downgraded by a half point due to qualitative heterogeneity (different drug regimens and study methods).<br/> <sup>4</sup>Imprecision: downgraded by 2 for wide CIs and very few clinical events.<br/> <sup>5</sup>Risk of bias: downgraded by 1 as IRIS outcome assessors in <a href="./references#CD009012-bbs2-0001" title="BissonGP , MolefiM , BellamyS , ThakurR , SteenhoffA , TamuhlaN , et al. Early versus delayed antiretroviral therapy and cerebrospinal fluid fungal clearance in adults with HIV and cryptococcal meningitis. Clinical Infectious Diseases2013;56(8):1165‐73. [DOI: 10.1093/cid/cit019; CN‐00861211] ">Bisson 2013</a> were unblinded.<br/> <sup>6</sup>Indirectness: downgraded 1 as despite case definition, diagnosing IRIS can be very subjective/misdiagnosed.<br/> <sup>7</sup>Risk of bias: downgraded by 2 as not all those who were randomized to early or delayed ART received ART. In addition, not all those who received ART had a viral load done. It cannot be assumed that these results are missing at random. This is explored in the sensitivity analyses.<br/> <sup>8</sup>Imprecision: downgraded by 1 for few clinical events (&lt; 200). </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Early ART compared to delayed ART initiation in HIV‐positive people with cryptococcal meningitis</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD009012.pub3/full#CD009012-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD009012-tbl-0002"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Cohort studies evaluating time to ART initiation in cryptococcal meningitis</span></div> <tbody> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Trial ID</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Design</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Location</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Definitions</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Study period</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Duration of follow‐up</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="3" rowspan="1" valign="top"> <p><b>Mortality</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Trial conclusions</b> </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Early</b> </p> <p><b>(n/N)</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Late</b> </p> <p><b>(n/N)</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Association</b> </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD009012-bbs2-0008" title="ManosuthiW , ChottanapundS , SungkanuparphS . Mortality rate of early versus deferred initiation of antiretroviral therapy in HIV‐1‐infected patients with cryptococcal meningitis. Journal of Acquired Immune Deficiency Syndromes2008;48(4):508‐9. ">Manosuthi 2008</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Retrospective cohort</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Thailand</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Early &lt; 1 month; late ≥ 1 month</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2002 to 2006</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1050 patient years</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>9/52</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>46/229</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Adjusted HR 0.833 (95% CI 0.379 to 1.831)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No difference, however underpowered and risks of selection bias and unmeasured confounders</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD009012-bbs2-0018" title="Crabtree RamírezB , Caro VegaY , SheperdBE , LeC , TurnerM , FrolaC , et al. Outcomes of HIV‐positive patients with cryptococcal meningitis in the Americas. International Journal of Infectious Diseases2017;63:57‐63. ">Crabtree Ramírez 2017</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Retrospective cohort</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>USA and Latin America</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Early &lt; 2 weeks; late 2 to 8 weeks</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1985 to 2014</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unknown</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>7/24</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>14/53</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Adjusted OR 1.09 (95% CI 0.44 to 2.67)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No difference, however underpowered and risks of selection bias and unmeasured confounders</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD009012-bbs2-0026" title="IngleSM , MiroJM , FurrerH , JusticeA , SaagMS , ManzardoC , et al. Impact of ART on mortality in cryptococcal meningitis patients: high‐income settings. Conference on Retroviruses and Opportunistic Infections (CROI); 2015 Feb 23‐25; Seattle (WA). San Francisco: CROI Foundation/IAS‐USA, 2015:Poster 837. ">Ingle 2015</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Retrospective cohort (conference abstract)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>North America</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Early ≤ 14 days; late 14 to 56 days since cryptococcal meningitis diagnosis</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1998 to 2009</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unknown</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>7/62</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>7/67</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Crude HR 1.29 (0.68 to 2.43) and adjusted HR 1.30 (0.66 to 2.55)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No association between timing and mortality, however unmeasured confounders and selection bias an issue. </p> <p>Low power to detect a difference</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="10"> <div class="table-footnote"> <p>Abbreviations: ART: antiretroviral therapy; CI: confidence interval; HR: hazard ratio; OR: odds ratio </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Cohort studies evaluating time to ART initiation in cryptococcal meningitis</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD009012.pub3/full#CD009012-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD009012-tbl-0003"> <div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Summary of included studies</span></div> <tbody> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Trial ID</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Country</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Randomized</b> </p> <p><b>(N)</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Male (N; %)</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Age (median; IQR or mean; SD)</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Duration of antifungal therapy prior to randomization</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Antifungal regimen</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p><b>Time to ART initiation after randomization</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>ART regimen<sup>1</sup> </b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Dropouts (N)</b> </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Early</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Delayed</b> </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD009012-bbs2-0001" title="BissonGP , MolefiM , BellamyS , ThakurR , SteenhoffA , TamuhlaN , et al. Early versus delayed antiretroviral therapy and cerebrospinal fluid fungal clearance in adults with HIV and cryptococcal meningitis. Clinical Infectious Diseases2013;56(8):1165‐73. [DOI: 10.1093/cid/cit019; CN‐00861211] ">Bisson 2013</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Botswana</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>28</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>14; 50</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>35 (32 to 41)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>72 hrs</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Amphotericin B and fluconazole</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>7 days (range 5 to 10)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>32 days (range 28 to 36)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>TDF/FTC/EFV or NVP</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD009012-bbs2-0002" title="BoulwareDR , MeyaDB , MuzooraC , RolfesMA , Huppler HullsiekK , MusubireA , et al. Timing of antiretroviral therapy after diagnosis of cryptococcal meningitis. New England Journal of Medicine2014;370(26):2487‐98. [DOI: 10.1056/NEJMoa1312884; CN‐00994166] ">Boulware 2014</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Uganda, South Africa</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>177</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>93; 53</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>35 (28 to 40) early;</p> <p>36 (30 to 40) delayed</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>7 to 11 days</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Amphotericin B and fluconazole</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 to 2 weeks after diagnosis</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5 weeks after diagnosis</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>AZT/3TC/ EFV (80%),</p> <p>D4T/3TC/EFV (19%),</p> <p>TDF/3TC/EFV (1%)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD009012-bbs2-0003" title="MakadzangeAT , NdhlovuCE , TakarindaK , ReidM , KurangwaM , GonaP , et al. Early versus delayed initiation of antiretroviral therapy for concurrent HIV infection and cryptococcal meningitis in sub‐Saharan Africa. Clinical Infectious Diseases2010;50(11):1532‐8. [DOI: 10.1086/652652; CN‐00748368] ">Makadzange 2010</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Zimbabwe</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>54</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>28; 52</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>37 (SD 8.5) early;</p> <p>38 (SD 6.9) delayed</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0 days</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Fluconazole</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>72 hours</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>10 weeks</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>D4T/3TC/ NVP</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD009012-bbs2-0004" title="ZolopaA , AndersenJ , PowderlyW , SanchezA , SanneI , SuckowC , et al. Early antiretroviral therapy reduces AIDS progression/death in individuals with acute opportunistic infections: a multicenter randomized strategy trial. PLoS ONE2009;4(5):e5575. [DOI: 10.1371/journal.pone.0005575; CN‐00702077] ">Zolopa 2009</a><sup>2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>USA, Puerto Rico, South Africa</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>35</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NR</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NR</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>≤ 14 days</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NR</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>48 hours</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6 to 12 weeks</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NNRTI or PI + 2 NRTIs (3TC or FTC)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NR</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="11"> <div class="table-footnote"> <p>Abbreviations: IQR: interquartile range; N: number of participants; NR: not reported; SD: standard deviation; AZT: Zidovudine; D4T: Stavudine </p> <p><sup>1</sup>TDF: tenofovir; FTC: emtricitabine; EFV: efavirenz; NVP: nevirapine; 3TC: lamivudine; NNRTI: non‐nucleoside reverse transcriptase inhibitor; NRTI: nucleoside reverse transcriptase inhibitor; PI: protease inhibitor.<br/> <sup>2</sup>This trial reported results for participants with a variety of opportunistic infections and did not provide descriptive data specifically for those with cryptococcal meningitis. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Summary of included studies</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD009012.pub3/full#CD009012-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD009012-tbl-0004"> <div class="table-heading"><span class="table-label">Table 3.</span> <span class="table-title">Cerebrospinal fluid fungal clearance results</span></div> <tbody> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Trial ID</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Number of participants assessed for this outcome</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Trial conclusions </b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p><b>Results</b> </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Early ART</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Delayed ART</b> </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD009012-bbs2-0001" title="BissonGP , MolefiM , BellamyS , ThakurR , SteenhoffA , TamuhlaN , et al. Early versus delayed antiretroviral therapy and cerebrospinal fluid fungal clearance in adults with HIV and cryptococcal meningitis. Clinical Infectious Diseases2013;56(8):1165‐73. [DOI: 10.1093/cid/cit019; CN‐00861211] ">Bisson 2013</a><sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>28</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No difference between groups</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Rate of fungal clearance: ‐0.32 log<sub>10</sub> CFUs/mL/day </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Rate of fungal clearance: ‐0.52 log<sub>10</sub> CFUs/mL/day </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD009012-bbs2-0002" title="BoulwareDR , MeyaDB , MuzooraC , RolfesMA , Huppler HullsiekK , MusubireA , et al. Timing of antiretroviral therapy after diagnosis of cryptococcal meningitis. New England Journal of Medicine2014;370(26):2487‐98. [DOI: 10.1056/NEJMoa1312884; CN‐00994166] ">Boulware 2014</a><sup>2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>166</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No difference between groups</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CSF culture positivity at 14 days of amphotericin B therapy: cumulative incidence of 37% (95% CI 26% to 49%) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CSF culture positivity at 14 days of amphotericin B therapy: cumulative incidence of 39% (95% CI 28% to 50%) </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="5"> <div class="table-footnote"> <p>Abbreviations: CFU: colony forming units; CI: confidence interval; CSF: cerebrospinal fluid </p> <p><sup>1</sup>The trial authors reported: "The median numbers of CSF CFU measurements for the control and intervention arms, respectively, were 3 (IQR, 2–4 [range, 1–9]) and 4 (IQR, 2–5 [range, 1–7]) (P = .2, rank‐sum test). The generalized estimating equation regression coefficient for the intervention was 0.20 (95% CI, ‐.85 to 1.25), indicating that intervention subjects had a rate of CSF clearance that tended to be 0.20 log10 CSF CFU/mL/day slower than controls, although this difference was not significant."<br/> <sup>2</sup>The trial authors reported: "Similar rates of CSF culture positivity at 14 days (37% in the earlier‐ART group and 39% in the deferred‐ART group, P = 0.87). Among 59 participants with positive CSF cultures at 14 days, the median cryptococcal growth was 100 CFU per millilitre (interquartile range, 15 to 500), with no significant difference between treatment groups (P = 0.13); only 5 participants had more than 10,000 CFU per millilitre in CSF." </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 3.</span> <span class="table-title">Cerebrospinal fluid fungal clearance results</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD009012.pub3/full#CD009012-tbl-0004">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD009012-tbl-0005"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Early versus delayed ART</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 All‐cause mortality at 6 to 12 months <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>294</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.42 [1.02, 1.97]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Sensitivity analysis: all‐cause mortality <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Cryptococcal meningitis relapse <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>205</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.27 [0.07, 1.04]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Mortality hazard ratio <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Hazard Ratio (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Cryptococcal IRIS <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>205</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.56 [0.51, 25.02]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Sensitivity analysis: cryptococcal IRIS <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.1 Available‐case analysis: all who received ART (assume missing completely at random)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>178</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.97 [0.38, 23.25]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.2 As randomized: intention‐to‐treat analysis</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>205</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.56 [0.51, 25.02]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.3 Worst‐case scenario</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>205</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.73 [0.37, 38.07]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.4 Best‐case scenario</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>205</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.56 [0.45, 5.40]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Virological suppression at 24 weeks (viral load &lt; 400 copies/mL) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>205</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.93 [0.72, 1.22]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Sensitivity analysis: virological suppression at 24 weeks <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.1 Available‐case analysis (assume missing completely at random)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>128</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.10 [0.96, 1.27]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.2 Intention‐to‐treat analysis (assume missing would not have suppressed)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>205</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.93 [0.72, 1.22]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.3 Best‐case scenario</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>205</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.26 [1.10, 1.45]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.4 Worst‐case scenario</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>205</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.84 [0.72, 0.96]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9 Subgrouping by antifungal drug: all‐cause mortality <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.1 Ampho B + fluconazole</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.2 Fluconazole</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.3 Unknown antifungal drug</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Early versus delayed ART</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD009012.pub3/references#CD009012-tbl-0005">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD009012.pub3&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="es#CD009012-note-0001">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD009012-note-0003">فارسی</a> </li> <li class="section-language"> <a class="" href="ms#CD009012-note-0002">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="zh_HANS#CD009012-note-0010">简体中文</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738735355000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738735355000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774000000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774074000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774074000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774000000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009012\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD009012\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009012\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD009012\x2epub3"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009012\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD009012\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009012\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD009012\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009012\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD009012\x2epub3"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009012\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD009012\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009012\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD009012\x2epub3"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009012\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD009012\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009012\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD009012\x2epub3"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=QzbxnhyM&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD009012.pub3&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD009012.pub3';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD009012.pub3/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD009012.pub3/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD009012.pub3%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740717956345"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD009012.pub3/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740717956348"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD009012.pub3/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918dc4959a999377',t:'MTc0MDcxNzk1Ni4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 